High Intensity Focused Ultrasound Therapy Market Sales, Price, Revenue, Gross Margin and Share 2027 – CueReport
A Research study on High Intensity Focused Ultrasound Therapy Market analyzes and offers ideas of exhaustive research on ancient and recent High Intensity Focused Ultrasound Therapy market size. Along with the estimated future possibilities of the market and emerging trends in the High Intensity Focused Ultrasound Therapy market.
The global high-intensity focused ultrasound therapy market is expected to reach US$ 417.98 Mn in 2018 and is predicted to grow at a CAGR of 7.1% during the forecast period 2019 2027, to reach US$ 755.46 Mn by 2027.
Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/7739
Therapeutic ultrasound segment held a largest market share of the High-Intensity Focused Ultrasound therapy market. This segment is also expected to dominate the market in 2027 because it increases the healing rates, tissue relaxation, and its heating, local blood flow, and scar tissue breakdown. Moreover, others segment is expected to grow at significant rate, in the forecast period 2019 to 2027 because lithotripsy, thrombolysis, immunomodulation, and among others medical procedures are increasing.
Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/7739
The market for high-intensity focused ultrasound therapy is expected to grow, owing to factors such as growing cancer prevalence across the globe, rising incidences of kidney stone and prostate diseases, rising preference for non-invasive procedures. In addition, growing hospital industry in developing nations are likely to have a positive impact on the growth of the market in the coming years.
What will you get in this report?
Genetic testing helps evaluate the chance of developing cancer in a lifetime. The genetic testing is done by searching for specific mutations in genes, chromosomes, or proteins. An inherited gene mutation causes hereditary cancer. An inherited gene is the one which is passed from parent to child in a family. Various methods are used for hereditary cancer testing; it includes genetic counseling. The counseling provides a discussion regarding recommendations for preventive care and screening with the patient. They support groups and other information resources and provide emotional support to the person getting the results.
Global high-intensity focused ultrasound therapy market is segmented by modality, method, application, and end user. On the basis of modality, the market is segmented into Therapeutic Ultrasound, Hemostasis, Others. On the basis of method, the market is segmented into Non-Invasive and Minimal-Invasive. On the basis of Application, the market is segmented into Uterine Fibroids, Prostate Cancer, Others. Based on end user, the market is segmented into Hospitals, Research Centers, and Diagnostic Centers. In 2018, the imaging held the largest share in the market, by diagnosis type.
Some of the major primary and secondary sources included in the report are, Food and Drug Administration, World Health Organization (WHO), Centers for Medicare & Medicaid Services (CMS), Cancer Organisation Soutien (CDS), National Institute of Cancer Prevention and Research (NICPR), National Cancer Institute, Canadian Institutes of Health Research (CIHR), Spanish Society of Medical Oncology (SEOM), and others.
A Pin-point overview of TOC of High Intensity Focused Ultrasound Therapy Market are:
Overview and Scope of High Intensity Focused Ultrasound Therapy Market
High Intensity Focused Ultrasound Therapy Market Insights
Industry analysis - Porter's Five Force
Company Profiles
Request Customization on This Report @ https://www.cuereport.com/request-for-customization/7739
Go here to see the original:
High Intensity Focused Ultrasound Therapy Market Sales, Price, Revenue, Gross Margin and Share 2027 - CueReport
Recommendation and review posted by Bethany Smith
Gene Therapy Partnering Terms and Agreements Market 2020 Global Analysis, Growth Opportunities, Top Key Players – Owned
The report on Global Gene Therapy Partnering Terms and Agreements 2014 to 2020 is suitably segmented and sub-segmented so that it can shade light on every aspect of market such as type of product, application, and region. On the basis of recent developments and past data, the report prophesies future revenue, growth, and trend of the Gene Therapy Partnering Terms and Agreements Market landscape. This information is represented in curves, tables, margins, pie charts. Additionally, it emphasizes on faster growing segments and emerging trends in the market. The report provides an in-depth insight into the global Gene Therapy Partnering Terms and Agreements Market covering all important parameters that cover Market Challenge, Driver, Trend and Forecast.
Key Companies Involved in This Report: Company A
Get Free Sample PDF Of Gene Therapy Partnering Terms and Agreements Market @https://www.researchmoz.us/enquiry.php?type=S&repid2696112
Scope of Gene Therapy Partnering Terms and Agreements Market: The report forecast global Gene Therapy Partnering Terms and Agreements market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period 2020-2026. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers revenue. Estimates of the regional markets for Gene Therapy Partnering Terms and Agreements are based on the applications market.
As per the research and study, the market has settled its presence worldwide. Gene Therapy Partnering Terms and Agreements Market Research study offers a comprehensive evaluation of the Market and comprises a future trend, current growth factors, focused opinions, details, and industry certified market data.
Gene Therapy Partnering Terms and Agreements Market Report Answers Important Questions which include
Gene Therapy Partnering Terms and Agreements Market Report Answers Important Questions which include:
End-use Industry Assessment
The report segments the Gene Therapy Partnering Terms and Agreements Market on the basis of end-use industry and offers a detailed understanding of the supply-demand ratio and consumption pattern of the Gene Therapy Partnering Terms and Agreements in each end-use industry.On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, Gene Therapy Partnering Terms and Agreements market share and growth rate of Gene Therapy Partnering Terms and Agreements foreach application, including-
On the basis of product,this report displays the sales volume, revenue (Million USD), product price, Gene Therapy Partnering Terms and Agreements market share and growth rate ofeach type, primarily split into-
Gene Therapy Partnering Terms and Agreements Market Regional analysis includes:
Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2696112
Research Objectives and Purpose:
1. To inquire and examine the Gene Therapy Partnering Terms and Agreements market size by important regions/countries, product type and application, past data from 2014 to 2018, and estimate or forecast to 2026.2. To know the structure of Gene Therapy Partnering Terms and Agreements Market by recognizing its several sub-segments.3. To focused on a key Gene Therapy Partnering Terms and Agreements market players, to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.4. To interpret the Gene Therapy Partnering Terms and Agreements market concerning specific growth trends, prospects, and their contribution to the total market.5. To share detailed information about the key factors impacting the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).6. To project the size of Gene Therapy Partnering Terms and Agreements Market, concerning key regions, type, and applications.7. To explain competitive developments such as expansions, agreements, new product launches and acquisitions in the market and much more.
For More Information Kindly Contact: ResearchMozMr. Rohit Bhisey,90 State Street,Albany NY,United States 12207Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Media Release @ https://www.researchmoz.us/pressreleaseFollow me on Blogger: https://trendingrelease.blogspot.com/
Read the original here:
Gene Therapy Partnering Terms and Agreements Market 2020 Global Analysis, Growth Opportunities, Top Key Players - Owned
Recommendation and review posted by Bethany Smith
2020 Growth: Thalassemia Treatment Market 2020 Industry Research, Segmentation, Key Players Analysis and Forecast to 2025 – Cole of Duty
Global Thalassemia Treatment Market Research Report Cover Covid-19 Impact
The Thalassemia Treatment market research report fabricated by Brand Essence Market Research is an in-depth analysis of the latest trends persuading the business outlook. The report also offers a concise summary of statistics, market valuation, and profit forecast, along with elucidating paradigms of the evolving competitive environment and business strategies enforced by the behemoths of this industry.
Download Premium Sample of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=57&RequestType=Sample
Global Thalassemia Treatment Market 2018-2024Brandessence Market Research is working on a new report titleGlobal Thalassemia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024?. Rise in number of altered Thalassemia genes, increase in awareness about the disease and high adoption of chelation therapy & blood transfusion for treatment by doctors as well as patients arelikely to enhance the growth of Global Thalassemia Treatment Market.
Scope of Global Thalassemia Treatment Market Reports
Thalassemia is aninherited blood disorder in which the body makes an abnormal form of hemoglobin.People having Thalassemia disease are unable to make sufficient hemoglobin which causes severe anemic conditions.Hemoglobin is found in red blood cells and transports oxygen to all parts of the body. When there is insufficient hemoglobin in the red blood cells, oxygen cannot get to all parts of the body. Organs demand oxygen and are unable to function properly.There are two primary types of Thalassemia disease such as Alpha Thalassemia disease and Beta Thalassemia disease.Alpha Thalassemia results in a formation of additional beta globins, which leads to the formation of beta-globin tetramers (4) called Hemoglobin H.
Beta Thalassemia causesadditionalformation of alpha globins, which develops alpha globin tetramers (a4) that store in the erythroblast (immature red blood cell).Thalassemia is caused by mutations in the DNA of cells that make hemoglobin.
Factors that increase risk of Thalassemia include Family history of thalassemia and certain ancestry.Possible complications of Thalassemia includeIron overload, Infections, Bone deformities, splenomegaly, slowed growth rate of child and Heart problems.
Thalassemia signs and symptoms include Fatigue, Weakness, Pale or yellowish skin, Facial bone deformities, slow growth, abdominal swelling, Dark urine, chest pain,cold hands and feet, poor feeding, greater susceptibility to infections. Diagnosis of Thalassemia includesa complete blood count (CBC), a reticulocyte count,Iron count, Genetic testing and prenatal testing. Treatment of Thalassemia depends on the type and severity of Thalassemia such as Blood transfusions, Bone marrow or stem cell transplant, Surgery and Gene therapy.
Global Thalassemia Treatment Market has been segmented on the basis ofType of Treatment, Diagnosis, End usersand Geography. On the basis of Type of TreatmentGlobal Thalassemia Treatment Market is classified into Blood Transfusion, Chelating Therapy, Bone Marrow Transplant, Stem Cell Transplant, Surgery, Gene Therapy and Others.On the basis of DiagnosisGlobal Thalassemia Treatment Market is classified into Perinatal Testing, Prenatal Testing, Pre-Implantation and Other.On the basis of the End user the Global Thalassemia Treatment Market is classified into Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries and others.
The regions covered in Global Thalassemia Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Thalassemia Treatment Market Reports
Global Thalassemia Treatment Market reports cover prominent players like Bluebird bio Inc., Acceleron Pharma Inc., Novartis AG, Celgene Corporation, Shire plc, Bellicum Pharmaceuticals, GlaxoSmithKline Plc, Celgene,Lonza group, Alnylam Pharmaceuticals Inc., Calimmune Inc., CRISPR Therapeutics, Editas Medicine Inc., Errant Gene Therapeutics LLC, Gamida Cell Ltd, Gilead Sciences Inc., Incyte Corp, Ionis Pharmaceuticals Inc., IRBM Science Park SpA, Johnson & Johnson, Kiadis Pharma NV, La Jolla Pharmaceutical Company, Merck & Co Inc., PharmaEssentia Corp, Protagonist Therapeutics Inc., Sangamo Therapeutics Inc., Zydus Cadila Healthcare Ltd, Genorama Ltd, HiMedia Laboratories, DiagCor Bioscience Inc. Ltd and Tosoh Bioscience Inc.
Global Thalassemia Treatment Market Dynamics
Increase in awareness about the disease and technological expansions are likely to raise the adoption of gene therapies. Also Rising Prevalence of Thalassemia, Increase in Pharmaceutical R&D Spending, Increasing Spending on Stem Cell Research, Rising Healthcare Expenditure and Rising Asian Population will boost theGlobal Thalassemia Treatment Market. Treatment of Thalassemia is mostly restricted to regular blood transfusions and iron chelation therapy.Moreover, High operation cost of sophisticated clinical and preclinical imaging systems, High cost of maintenance andless life span of accessoriesalso restraining theGlobal Thalassemia Treatment Market.Yearlyspending for treatment of Thalassemia ranged from $ 108 to 432, depending on type of treatment with average cost per blood transfusion was $ 5.22.2. Average 18.5%14.3 of the total annual income was spent on the treatment for Thalassemia. Drugs prescribed for Thalassemia mostly cures symptoms and side effects such as anemia, iron overload, slow growth of children and vitamin deficiency.Occurrence of Thalassemia is reported to increase steadily over the years across different regions. This can be due to population migration, intermarriages, genetic as well as environmental factors prompting the condition and its implications.Systematic Drugs under Pipeline, Rising Scope for Gene Therapy and increasing awareness towards Thalassemia are some opportunities in the forecast period for theGlobal Thalassemia Treatment Market.
Global Thalassemia Treatment MarketRegional Analysis
North America have largest share ofGlobal Thalassemia Treatment Market. It is mainly driven by quickly increasing immigrant population from tropical regions, rising number of population with Thalassemia carrier gene and rise in birth rates due to variation of genes among the population in the U.S.There are some prenatal tests available on the market to determine the possibility of alpha thalassemia including both invasive and non-invasive technique.
The alpha thalassemia testing market has aemergent trend in the countries with traditional groups like Mediterranean countries, African countries and few countries in Asia Pacific. Furthermore, in Asia Pacific region the growth in similar community marriage practices and high fertility ratewith alpha thalassemia patients have been detected. This is expected to raiseacceptance of blood transfusion and chelation therapy treatments during the forecast period.A latestimprovement in the testing of alpha Thalassemia may determine the risk of the disease by in vitro examination of the embryo. While there are various such tests available in theGlobal Thalassemia Treatment Market but lack of awareness leads to the neglect and delayed diagnosis of the diseased state.
Most frequently prone area for alpha thalassemia is Mediterranean countries, African countries, and Southeast Asian countries. Thalassemia trait practically affects 6% to 35% of the population in these ethnic groups. Middle East & Africa is likely to be the fastest risingGlobal Thalassemia Treatment Market during the forecast period.
Key Benefits for Global Thalassemia Treatment Market Reports
Global Thalassemia Treatment Market report covers in depth historical and forecast analysis.Global Thalassemia Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.Global Thalassemia Treatment Market report helps to identify opportunities in market place.Global Thalassemia Treatment Market report covers extensive analysis of emerging trends and competitive landscape.Global Thalassemia Treatment Market Segmentation
Global Thalassemia Treatment Market: By Type of Treatment Analysis
Blood TransfusionChelating TherapyBone Marrow TransplantStem Cell TransplantSurgeryGene TherapyOtherGlobal Thalassemia Treatment Market: By Diagnosis Analysis
Perinatal TestingPrenatal TestingPre-ImplantationOtherGlobal Thalassemia Treatment Market: By End user Analysis
HospitalsBiotechnological LaboratoriesDiagnostic LaboratoriesEducational Research InstitutesPharmaceutical IndustriesOtherGlobal Thalassemia Treatment Market: By Regional & Country Analysis
North AmericaU.S.MexicoCanadaEuropeUKFranceGermanyItalyAsia PacificChinaJapanIndiaSoutheast AsiaLatin AmericaBrazilThe Middle East and AfricaGCCAfricaRest of Middle East and Africa
Request Customization of the Report: https://industrystatsreport.com/Request/Sample?ResearchPostId=57&RequestType=Customization
Key Reasons to Purchase:
To gain insightful analyses of the market and a comprehensive understanding of the impact of COVID-19 is likely to have on the Drones Market during the forecast period between 2020 and 2026, and its commercial landscapeTo learn about the market strategies that are being adopted by your competitors and other leading companiesTo understand the future outlook and prospects of the Drones Market post COVID-19To keep you abreast with the strategies used by other players in theTo understand the changes in rules and regulations in various countries during COVID-19 and its possible effects on the market in the future.
About Us:
We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.
Top Trending Reports:
Recommendation and review posted by Bethany Smith
Rare Disease Diagnostics: Technologies and Global Markets Cole Reports – Cole of Duty
Summary:
Rare diseases comprise a growing public health priority, as they affect upward of 300 million people globally and they are difficult to diagnose and treat.
There is a pressing need for better ways to detect and diagnose rare diseases, as well as to provide companion diagnostics for therapy guidance, clinical trials enrollment and therapy monitoring applications.
Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4747004
Better diagnostic tests for rare diseases can make significant differences in the lives of those affected by these conditions. Many rare diseases go undiagnosed for long periods of time because patients, families and physicians may have limited awareness of certain diseases, and the symptoms may not be informative to healthcare workers who may not have encountered such diseases before.
An extended time to diagnosis of a rare disease, along with so-called diagnostic odysseys, can lead to negative outcomes, including misdiagnosis or disease progression. Rapid, accurate diagnostics can significantly shorten these diagnostic odysseys.
In addition to early detection and diagnostic potential, rare disease therapeutics will be important in orphan drug development and use. Orphan drugs address rare disease patient populations, and they are expected to have a high growth rate through 2024. By 2024, orphan drugs may make up as much as onefifth of global prescription sales. Rare disease diagnostics can be used to help physicians make proper decisions regarding which therapies to use and ways to monitor the efficacy of those therapies during treatment courses. Rare disease diagnostics can also be used to help select patients for orphan drug clinical trials.
More than 70% of rare diseases are inher+N13ited conditions, and they thus have genetic components, so this industry relies heavily on genetic analysis methods, including polymerase chain reaction (PCR), nextgeneration sequencing (NGS) and Sanger sequencing.
Report Scope:
The scope of the report includes rare disease diagnostic technologies, applications, industries, initiatives, patents and companies. The market for rare disease diagnostic products and services is given for 2018 and 2019, and then forecast through 2024.
Browse the complete report @ https://www.orbisresearch.com/reports/index/rare-disease-diagnostics-technologies-and-global-markets
This report reviews the main diagnostic technologies and explains why genetic variation is important in clinical testing and disease. It then discusses significant large-scale research initiatives that impact rare disease diagnostic applications. Of particular interest is a discussion of global population-scale sequencing projects and their likely impact in linking genetic variation to rare disease diagnostics. The main market driving forces for rare disease diagnostic products and services are listed and discussed.
The report categorizes and quantifies the rare disease diagnostics market by the disease category, technology platform, test purpose, analysis target and geography segments.
Disease categories include cardiovascular; central nervous system; endocrine and metabolic; immune and inflammation; musculoskeletal; ophthalmology; rare cancers; respiratory; and other (gastro-intestinal, Genito-urinary, dermatology and lymphatic categories.
Technology platforms include: mass spectrometry, microarrays, next-generation sequencing (NGS), PCR, Sanger sequencing and other (e.g., karyotyping, fluorescent in situ hybridization).
Test purposes include: screening and early detection, diagnosis, therapy guidance and monitoring.
Analysis targets include single gene, multi-gene panels, whole exome, whole genome, other genomic variants and proteins.
Geographical regions include the Asia-Pacific region, Europe, North America and the Rest of the World (ROW).
Industry sectors influencing rare disease diagnostics discussed in the report include next-generation sequencing, long-read sequencing, PCR, RNA therapies, gene-editing therapies, gene therapies, and genetically modified cell therapies.
More than 95 companies in the rare disease diagnostic industry are profiled in this report.
BCC Research also provides a summary of more than 50 of the main industry acquisitions and strategic alliances that took place from April 2018 through April 2020, including key alliance trends.
Report Includes:
53 tables An overview of the global markets and technologies for rare disease diagnostics and discussion on market opportunities for these technologies Analyses of global market trends with data from 2018, 2019 and projections of compound annual growth rates (CAGRs) through 2024 Evaluation of current market size, market forecast and description of market driving forces Detailed market share analysis and quantification of rare disease diagnostics markets by disease class, indication, analysis platform, analysis target, test purpose and region Briefing about rare disease therapies and how they influence the use of rare disease diagnostics Details about Orphan Drug Act and other initiatives for rare diseases Coverage of the key industries associated with developing and marketing rare disease diagnostics, including the DNA sequencing industry, PCR industry, and laboratory services industry A look at the key industry acquisitions and strategic alliances and discussion on the key partnering trends Profiles of key companies in the rare disease diagnostics industry, including 10x Genomics Inc., Agilent Technologies Inc., Freenome Inc., GenapSys Inc., Illumina Inc., Myriad Genetics Inc. and PerkinElmer Inc.
Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4747004
Companies Mentioned:10X GENOMICS INC.23ANDME INC.3BILLION INC.ADAPTIVE BIOTECHNOLOGIES INC.ADMERA HEALTHAGILENT TECHNOLOGIES INC.ALCEDIAGAMARANTUS BIOSCIENCE HOLDINGS INC.AMBRY GENETICSARCHIMEDLIFE LABORATORIESARUP LABORATORIESASTRIDBIO TECHNOLOGIES KFT.ASURAGEN INC.ATHENA DIAGNOSTICS INC.BASE4 INNOVATION LTD.BAYLOR GENETICSBC PLATFORMSBERRY GENOMICS CO., LTD.BGI SHENZHENBIO-RAD LABORATORIES INC.BIOCEPT INC.CEGAT GMBHCELLMAX LIFECELSEE DIAGNOSTICSCENTOGENE AGCERGENTIS B.V.DANAHER CORP.DANTE LABSDEVYSER ABDIACARTA INC.DIPLOIDDIRECTED GENOMICS LLCDNANEXUS INC.ELECTRONIC BIOSCIENCESEPIC SCIENCES INC.EUROFINS SCIENTIFICEXPEDEON AGFABRIC GENOMICSFREENOME INC.FULGENT GENETICSFUSION GENOMICS CORP.GENAPSYS INC.GENEDX INC.GENEMIND BIOSCIENCES CO., LTD.GENETICS RESEARCH LLCGENEXOSOME TECHNOLOGIES INC.GENOMATIX SOFTWARE GMBHGENOME PROFILING LLCGENOMENONGENOMIC EXPRESSIONGENOMNIA SRLGENOMONCOLOGYGENOOXGENOSPACEGIGAGEN INC.GOLDEN HELIXGRANDOMICS BIOSCIENCES CO., LTD.GUARDIOMEHELIX OPCO LLCHTG MOLECULAR DIAGNOSTICS INC.ILLUMINA INC.INVITAE INC.KINGMED DIAGNOSTICS CENTER CO., LTD.LABORATORY CORP. OF AMERICA INC.LABORATORY FOR MOLECULAR MEDICINELEUCINE RICH BIO PVT., LTD.LOOP GENOMICSMACROGEN INC.MAYO MEDICAL LABORATORIESMEDGENOME LABS PVT., LTD.MOLECULAR LOOP BIOSOLUTIONS LLCMYRIAD GENETICS INC.NEW ENGLAND BIOLABSNEWGENE LTD.NOSTROS GENOMICSNOVOGENE CO., LTD.OXFORD NANOPORE TECHNOLOGIES LTD.PACIFIC BIOSCIENCES OF CALIFORNIA INC.PERKINELMER INC.PERSONAL GENOME DIAGNOSTICS INC.PREVENTIONGENETICS INC.Q-STATE BIOSCIENCESQUANTAPORE INC.QUANTUM BIOSYSTEMS INC.QUEST DIAGNOSTICS INC.REAL-TIME GENOMICS INC.RETROPHINROCHE HOLDING AGSEVEN BRIDGES GENOMICS INC.SISTEMAS GENOMICOS SLSOFTGENETICS LLCSOPHIA GENETICSSPERA MEDICALSTRAND LIFE SCIENCES PVT., LTD.SUPRATECH MICROPATH LABORATORY & RESEARCH INSTITUTE PVT., LTD.THERMO FISHER SCIENTIFIC INC.TWIST BIOSCIENCE
Original post:
Rare Disease Diagnostics: Technologies and Global Markets Cole Reports - Cole of Duty
Recommendation and review posted by Bethany Smith
Children’s Hospital Los Angeles Ranked No. 1 Children’s Hospital in the Western U.S., No. 5 Nationally for Second Straight Year – Business Wire
LOS ANGELES--(BUSINESS WIRE)--Children's Hospital Los Angeles (CHLA) ranks again among the nations premier destinations for pediatric care, according to the U.S. News & World Report Best Children's Hospitals annual list released today.
CHLA not only retained its national No. 5 ranking in U.S. News Honor Roll of Best Childrens Hospitalswhich recognizes institutions with the most outstanding pediatric clinical careit continued its four-year streak of being the highest-scoring childrens hospital in the entire Western United States.
To make U.S. News & World Reports prestigious Best Childrens Hospitals Honor Roll, one must demonstrate the strongest achievements in clinical excellence, with a matchless team of expert, compassionate specialists committed to research and education as well as protocols that drive safety and quality and consistently lead to the best health outcomes for patients, says CHLA President and Chief Executive Officer Paul S. Viviano. "This honor affirms the work of every CHLA team member and our belief that when parents choose Childrens Hospital Los Angeles, they are choosing the best care for kids."
Every year, U.S. News scores nearly every major hospital and health system in the country and ranks them according to performance benchmarks, peer review, certifications, and other data provided by the hospital and third-party measurements of excellence. Children's hospitals are ranked separately from other facilities due to the specialized expertise, equipment and facilities required to care for infants, children and youth.
This year, U.S. News surveyed 118 pediatric medical centers, including hospitals that are freestanding or part of a larger institution. CHLA improved its ranking over last year in seven of the 10 pediatric specialty categories the survey considers, including a number two ranking for Neonatal Care. In all, the hospital earned top-10 recognition in seven of those categories:
CHLA has an organization-wide commitment to providing our patients the care they need no matter their circumstances, says CHLA Chief Medical Officer James Stein, M.D., MSc. "Our clinical teams often treat the most acute cases that are outside the scope or expertise of other childrens hospitals in California, and being named a Top-5 childrens hospital in the U.S. is a testament to the clinicians and staff who work every day to make sure each child receives the best care and experience possible.
Founded in 1901, Children's Hospital Los Angeles is a pediatric academic medical center built around its mission of creating hope and building healthier futures for children. Renowned for its world-class clinical care, leading-edge research and one of the largest and most successful pediatric training programs in the countryall while being the pediatric safety net hospital for the entire regionCHLA now sees more than 600,000 patient visits annually between its main hospital and five neighborhood care clinics.
CHLA physicians, nurses and clinical staff provide compassionate and lifesaving pediatric care for patients ranging from infants to young adults, hailing from all 50 states and more than 75 countries. Clinical care is led by physicians who are faculty members of the Keck School of Medicine of USC. Many of the hospital's achievements in care are made possible through a cohesive relationship between clinical experts at the bedside and the basic, translational, and clinical research conducted in The Saban Research Institute of CHLA.
In the past year, CHLA has had several notable achievements, including:
U.S. News & World Report works with research firm RTI International to develop its annual Best Children's Hospitals list, a collaboration between hospitals and the magazine to benchmark the performance of childrens hospitals for the benefit of parents and their children. The survey evaluates hundreds of data points, including patient survival and surgical complication rates; staffing, technology and special services; infection prevention and delivery of care; reputation among peer physicians nationwide (i.e. Where would the best pediatric specialists send their kids?); how involved parents are in their childrens care; and many other measurements of excellence.
U.S. News Media Group, parent of U.S. News & World Report, announced the 2020-21 hospital rankings online at 12:01 a.m. EDT on Tuesday, June 16. For additional information, please visit the Best Childrens Hospitals Honor Roll and specialty rankings page at usnews.com/childrenshospitals.
About Children's Hospital Los Angeles
Founded in 1901, Children's Hospital Los Angeles is ranked the top childrens hospital in California and fifth in the nation for clinical excellence with its selection to the prestigious U.S. News & World Report Honor Roll of childrens hospitals. Clinical care is led by physicians who are faculty members of the Keck School of Medicine of USC through an affiliation dating from 1932. The hospital also leads the largest pediatric residency training program at a freestanding childrens hospital of its kind in the western United States. The Saban Research Institute of Childrens Hospital Los Angeles encompasses basic, translational and clinical research conducted at CHLA. The hospitals Center for Global Health facilitates services for international patients from more than 75 countries. To learn more, follow us on Facebook, Instagram, LinkedIn and Twitter, and visit our blog for families (CHLA.org/blog) and our research blog (ResearCHLABlog.org).
See the original post:
Children's Hospital Los Angeles Ranked No. 1 Children's Hospital in the Western U.S., No. 5 Nationally for Second Straight Year - Business Wire
Recommendation and review posted by Bethany Smith
Global Cell Culture Media Market 2020 with COVID-19 After Effects Analysis by Top Key Players | Life Technologies, Corning (Cellgro), Sigma-Aldrich,…
Cell Culture Media Industry Overview Competitive Analysis, Regional and Global Analysis, Segment Analysis, Market Forecasts 2026
TheCell Culture Media marketreport begins with the market overview/market definition and the market scope. This helps in understanding what exactly is the report study dealing with. The next section includes the target audience of the Cell Culture Media market. It is very important for the clients to understand what type of users or what kind of consumers deal with Cell Culture Media market in order to determine their focus goals.
Request Free Sample Copy of Cell Culture Media Market Research Report@http://www.marketresearchstore.com/report/global-cell-culture-media-market-by-player-region-321243#RequestSample
In the last section, the Cell Culture Media market report incorporates detailed information on the demand & supply chain analysis, import and export, industry size, sales volume, market shares, as well as value analysis of all the industry players operating in the Cell Culture Media market. Some of the major market players that are included areLife Technologies, Corning (Cellgro), Sigma-Aldrich, Thermo Fisher, Merck Millipore, GE Healthcare, Lonza, BD, HiMedia, Takara, CellGenix, Atlanta Biologicals, PromoCell, Zenbio. Each market player is profiles in detail within the report by the research analysts.
In the next section, the Cell Culture Media market report includes the research tools and methodologies that were incorporated while studying the Cell Culture Media market. For instance, Porters Five Force analysis, SWOT analysis, PESTLE analysis, top-down or the bottom-up approach that was used for market data analysis. It also includes details about the primary research and the secondary research that were conducted by the research analysts.
Read Detailed Index of full Research Study at::http://www.marketresearchstore.com/report/global-cell-culture-media-market-by-player-region-321243
The next major section of the Cell Culture Media market study includes the market segmentation. To understand any market with ease the market is segregated into segments, such as its product type, application, technology, end-use industry. By dividing the market into small components helps in understanding the market with more clarity. The market segments of the Cell Culture Media market includes{Classical Media & Salts, Serum-free Media, Stem Cell Media}; {Biopharmaceutical Manufacturing, Tissue Culture & Engineering, Gene Therapy, Cytogenetic}. The data that is provided within the study is both quantitative and qualitative. Data is represented with the help of tables and figures that include graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.
Another major segment of the Cell Culture Media market is its geographical presence on the global platform. The major regions that have been considered include Asia Pacific, Europe, Latin America, North America, and the Middle East and Africa. The Cell Culture Media market study is not restricted to regional level but also includes country-wise data.
If Any Inquiry of Cell Culture Media Report:http://www.marketresearchstore.com/report/global-cell-culture-media-market-by-player-region-321243#InquiryForBuying
Major Advantages for Cell Culture Media Market:
Well-organized description of the international Cell Culture Media market along with the ongoing inclinations and future considerations to reveal the upcoming investment areas. The all-inclusive market feasibility is examined to figure out the profit-making trends to obtain the most powerful foothold in the Cell Culture Media industry. The Cell Culture Media market report covers data which reveal major drivers, constraints, and openings with extensive impact analysis. The current market is quantitatively reviewed from 2019 to 2028 to pinpoint the monetary competency of the global Cell Culture Media market. Last but not least, PORTERS Five Forces Analysis shows the effectiveness of the customers and providers from a global perspective.
Go here to read the rest:
Global Cell Culture Media Market 2020 with COVID-19 After Effects Analysis by Top Key Players | Life Technologies, Corning (Cellgro), Sigma-Aldrich,...
Recommendation and review posted by Bethany Smith
Regenerative Medicine Market to Witness Growth Acceleration During 2020-2025 – Cole of Duty
The latest Regenerative Medicine Industry market research added by Market Study Report, LLC, delivers a concise outline regarding the potential factors likely to drive the revenue growth of this industry. The report delivers valuable insights on market revenue, SWOT Analysis, market share, profit estimation and regional landscape of this business vertical. Moreover, the report focuses on significant growth factors and obstacles accepted by market leaders in the Regenerative Medicine Industry market.
The Regenerative Medicine Industry market report is an in-depth analysis of this business space. The major trends that defines the Regenerative Medicine Industry market over the analysis timeframe are stated in the report, along with additional pointers such as industry policies and regional industry layout. Also, the report elaborates on the impact of existing market trends on investors.
Request a sample Report of Regenerative Medicine Industry Market at:https://www.marketstudyreport.com/request-a-sample/2727154
COVID-19, the disease it causes, surfaced in late 2020, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
Other information included in the Regenerative Medicine Industry market report is advantages and disadvantages of products offered by different industry players. The report enlists a summary of the competitive scenario as well as a granular assessment of downstream buyers and raw materials.
Revealing a gist of the competitive landscape of Regenerative Medicine Industry market:
Ask for Discount on Regenerative Medicine Industry Market Report at:https://www.marketstudyreport.com/check-for-discount/2727154
An outlook of the Regenerative Medicine Industry market regional scope:
Additional takeaways from the Regenerative Medicine Industry market report:
This report considers the below mentioned key questions:
Q.1. What are some of the most favorable, high-growth prospects for the global Regenerative Medicine Industry market?
Q.2. Which products segments will grow at a faster rate throughout the forecast period and why?
Q.3. Which geography will grow at a faster rate and why?
Q.4. What are the major factors impacting market prospects? What are the driving factors, restraints, and challenges in this Regenerative Medicine Industry market?
Q.5. What are the challenges and competitive threats to the market?
Q.6. What are the evolving trends in this Regenerative Medicine Industry market and reasons behind their emergence?
Q.7. What are some of the changing customer demands in the Regenerative Medicine Industry Industry market?
For More Details On this Report: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-regenerative-medicine-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020
Related Reports:
1. COVID-19 Outbreak-Global Clinical Pathology Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-clinical-pathology-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020
2. COVID-19 Outbreak-Global ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020Read More: https://www.marketstudyreport.com/reports/covid-19-outbreak-global-icad-intracranial-atherosclerotic-disease-pathology-industry-market-report-development-trends-threats-opportunities-and-competitive-landscape-in-2020
Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]
More here:
Regenerative Medicine Market to Witness Growth Acceleration During 2020-2025 - Cole of Duty
Recommendation and review posted by Bethany Smith
Autoimmune Experiments Switch Immune Cells From Attacking The Body to Protecting It – ScienceAlert
For most of us, the immune system works to protect us from bacteria, viruses, and other harmful pathogens.But for people with autoimmune conditions, the body's white blood cells instead perceive other cells and tissues in the body to be a threat and attacks them.
While some immune disorders, like allergies, can sometimes be treated, autoimmune conditions such as multiple sclerosis (MS) remain incurable.
Our research has shown that you can stop the immune system attacking the nerves which is what happens in MS. We did this by giving the immune system ever-increasing doses of the same molecule that the immune system was attacking.
Now we've taken this research one step further to show how this process works inside the white blood cells that make up the immune system.
Our team revealed the complex mechanisms that allow us to switch T cells (a type of white blood cell) from attacking the cells of autoimmune disease patients to protecting them.We learnt how to make reactive T cells tolerant.
Our T cells have evolved so that each one recognises different parts of the molecules made by pathogens (also known as antigens). When the T cells recognise antigens, the T cells start multiplying in order to attack the invaders.
The T cells move from a resting state into a highly activated state by turning on immune response genes that help them attack pathogens.
When an infection is over, some of these T cells remain, giving lifelong immunity as memory T cells. They're able to carry this lifelong memory by imprinting our chromosomes with triggers that allow immune response genes to be reactivated much faster.
In autoimmune diseases such as MS, Graves' disease and type 1 diabetes, the immune system gets it wrong. In MS, the T cells start to see myelin basic protein, a component of the outside, insulating coating that surrounds nerve cells, as an antigen.
They attack the nervous system and, as a result, MS sufferers lose control over their muscles. Our research is trying to rectify this.
To help us understand this process, we focused on the T cells that specifically recognise myelin basic protein as an antigen. We found that over time these T cells became less reactive after they were exposed to gradually increasing doses of the myelin basic protein.
This progressive exposure reprogrammed these T cells so that the signals telling the cells to attack the protein became weaker. This converted the T cells from attacking to protecting.
This switch could be explained by the fact that the immune system is regulated by two types of genes. One type tells the immune system to attack, while the other gene type silences the immune system to stop it going out of control.
We showed that when T cells are made tolerant, two of the most important genes that suppress the immune system were reprogrammed at the level of the chromosome to keep them more active.
Repetitive exposure to the myelin basic protein imprinted a memory within these inhibitory genes. This allowed T cells to remember to inhibit the T cell receptor from sending attack signals when they encountered that same specific myelin basic protein fragment.
The end effect of turning on the inhibitory genes was to weaken the signals inside T cells that would normally turn on other genes that activate the immune system. That meant that the T cells stopped getting the signal telling them to attack nerve cells.
Autoimmune diseases are currently treated using immunosuppressive drugs. The problem with this is that they suppress the whole immune system, making the patient prone to cancers and other infections.
Trials using antigen therapy in patients with MS and Grave's disease are ongoing, but results from short-term preliminary clinical trials showed both MS and Graves' disease patients started to have improved health while the trials lasted.
One day we hope that antigen-based immunotherapy will be able to deliver major benefits for all types of autoimmune disease. By detailing the complex mechanisms that control the fate of self-reactive T cells, we may have also opened the door for more specific therapies for these diseases.
Peter Cockerill, Professor, Institute of Cancer and Genomic Sciences, University of Birmingham and David C. Wraith, Professor of Immunology and Director, Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Read more:
Autoimmune Experiments Switch Immune Cells From Attacking The Body to Protecting It - ScienceAlert
Recommendation and review posted by Bethany Smith
Before genetically modified mosquitoes are released, we need a better EPA – The Boston Globe
While the attention of the American public has rightfully been focused on the COVID-19 pandemic, its associated racial disparities, and broader issues of structural racism, the US government made a serious public health decision one that could affect our health and our environment for generations to come.
Last month, the US Environmental Protection Agency approved the release of genetically modified mosquitoes. Under a 2-year Experimental Use Permit, a company called Oxitec has been granted permission to release over 1 billion genetically modified mosquitoes across 6,600 acres in Florida and Texas.
Oxitec hopes to demonstrate through field trials that their latest GM mosquito strain can reduce local populations of Aedes aegypti the mosquito species that transmits dengue fever, yellow fever, chikungunya, and the Zika virus. When males of this GM mosquito strain (OX5034) are continually released to mate in the wild, they pass on a lethal gene to their female offspring that causes female larvae to die before they can develop into biting adults. Male mosquito offspring survive, but male mosquitoes dont bite and without viable females, the population should eventually collapse.
EPA approval of the release of this new GM mosquito is just the first step toward Oxitec selling its proprietary mosquito to US mosquito-control boards, and by extension US taxpayers. Oxitec intends to deploy its GM mosquitoes in and around the Florida Keys and near Houston. If the appropriate local authorities agree, millions of GM mosquitoes could be released into the wild every week starting this summer.
With our combined scientific and policy expertise, neither of us is anti-genetically modified organisms. We eat GM foods and believe that GM technologies can have significant benefits to public health but only if they are used safely and fairly. The environmental introduction of the first GM mosquito in the United States is a landmark decision. Its public health, ecosystem, and societal risks and benefits should be carefully weighed.
In a recent press release, Oxitec claims its strategy is a safe and environmentally sustainable way to control mosquitoes that transmit disease. Yet the EPA did not convene an independent, external scientific advisory panel to review Oxitecs claim; the agencys risk assessment was only made publicly available after their approval decision and we know of no peer-reviewed articles on this particular GM mosquito strain.
Meanwhile, GM mosquitoes are being introduced into uncontained, shared environments that people live in and depend on. The EPA recently held a written public comment process that yielded over 31,000 comments where some worried the impacts of GM mosquito suppression could threaten food webs and strain already vulnerable ecosystems. Others feared GM mosquitoes, or their genetic material, could integrate into the wild; GM-wild hybrid mosquitoes could prove more difficult to control or better at spreading disease. (Several years ago, public meetings and a nonbinding referendum took place in Florida over a different Oxitec mosquito strain. Residents of Key Haven, the site of proposed trials, voted against the release.)
Oxitec has trialed their second generation GM mosquito in Brazil and succeeded in reducing local populations of Aedes aegypti. Given Brazils high mosquito-borne disease burden the country reported over 1.5 million probable cases of dengue fever in 2016 the potential benefits of GM mosquitoes may outweigh their unknown ecological risks. Yet in the United States, dengue outbreaks are relatively rare, yellow fever has been eradicated domestically, and 231 of documented Zika virus cases were caused by local mosquito transmissions, as opposed to those associated with travel. It is unclear whether the potential benefits of release in the United States (one could be chemical pesticide reductions) will outweigh the risks. These tradeoffs must be weighed in a public setting.
And herein lies our concern: Risks should not be assessed behind closed doors between technology developers and EPA employees. As designed, the EPA risk assessment process privileges private entities over the American public.
Several recommendations could be implemented to make the regulatory process more open, rigorous, and fair.
For starters, an external independent group of experts should be convened to review the first GM mosquitoes presented for release. To address the complexity of such a decision, this group should consist of interdisciplinary experts representing diverse identities with expertise in ecology, genetics, vector biology, risk assessment, entomology, public health, ethics, and social science. External peer review is a cornerstone of good science and could ensure that all necessary risks are being addressed.
To ensure rigorous review, the EPA and other regulatory bodies must also fund independent third-party research on GM mosquitoes and their potential impact on US ecosystems and human health. Potential risks are too important to be left to corporations alone to research, and the American public needs to be assured that these decisions are made free of conflicts of interest.
Lastly, and perhaps most important, people who live in areas of release must be consulted for their specialized, on-the-ground knowledge and for their right to have input in decisions that will affect them. Last week, the Florida Department of Agriculture and Consumer Services approved the EPA permit for experimental release. Oxitec must now get approval from the Florida Keys Mosquito Control Board. An independent group should host public conversations through local community venues, and it must make sure that structurally marginalized perspectives are at the center of those gatherings. But local community input should be consulted at every stage of the regulatory process, not after permits have already been granted. And earmarked government funding should support these local deliberations, as well as measures to amplify underrepresented perspectives in environmental regulation and biotechnology.
GMOs made with even more powerful genetic technologies like CRISPR gene editing and gene-drives are being created in the laboratory and considered for open-environmental release. The public needs to know that the risks and benefits of these decisions will likely impact us all, and certain communities even more so. The COVID-19 pandemic has made it clear that robust public health depends on informed communities who participate in collective actions. Release of GM mosquitoes is no different. For the health of ourselves, the nation, our planet, and future generations, environmental regulation of GMOs must be made more rigorous and just.
Natalie Kofler is founder of Editing Nature and an adviser for the Scientific Citizenship Initiative at Harvard Medical School. Jennifer Kuzma is a professor in the School of Public and International Affairs and co-director of the Genetic Engineering and Society Center.
The rest is here:
Before genetically modified mosquitoes are released, we need a better EPA - The Boston Globe
Recommendation and review posted by Bethany Smith
Around Town: Fathers matter – VVdailypress.com
Males, who have long been branded as the dominant gender in our species, have been undervalued since Eve turned Adam in to a hapless co-conspirator in the downfall of humanity.
We have a reputation of being driven by our animal passions and prejudices. Females get the credit for compassion and reason. With few exceptions in history, wars have not been started by women in power.
America has changed dramatically in its view of fatherhood and the responsibility the title entails. The one thing that remains constant in our society, and among our species, is that the young need direction, training, leadership and nurturing from a parent to thrive and sometimes even to survive.
Sadly, we are all products of our upbringing no matter how hard we try to remake ourselves as age and reason overtake us. My mother, God bless her, was a product of a five-sister home in the 30s. Getting out and getting a husband was vital. A man in her life was a life-long priority.
She had five husbands and a few other long-term relationships over her long life. I had three half-siblings fathered by her first husband. Then I came along with husband two after World War II. In a sense, I consider myself lucky because as I grew up, I had several choices of male role models. Some were winners, some were not. I got the genetics of being a big, garrulous hard drinker from my Irish birth father who drifted in and out of my life until he died after a drunken fall at age 47.
Sensing my needs, Mother then found a genial, well-known fellow who was the pillar of the community to take us in. It is his name, Orr, that I adopted when I came of age because it became clear to me even then that there are sperm donors and there are fathers. Do not confuse one with the other. Fathers contribute. They stay. They help. They teach and lead by example.
Ray Orr was a cop. He and his family of two older brothers were icons in Ontario for their contributions to youth sports. I was immediately accepted as a "good guy" when I entered high school simply trading on the goodwill of my new last name. It was an unimaginable gift. Acceptance, belonging and mentoring all in one fell swoop.
Ray also gave me one sage piece of advice that helped me keep on the straight and narrow through high school and college, an era of "free love" and doobies. He sat me down and said, "Pat, dont ever call me from jail because no one is coming. You are responsible for your actions."
That is fatherhood in my view.
I had another cop involved throughout my life that taught me about responsibility and hard work. My mom worked for the LAPD at the old Georgia Street Jail in the early 1950s and became friends with a sergeant named Lloyd Lindsey. He was a go-getter.
He and his wife had a third child and needed extra cash. He chose to take his vacation and work at a food stand at the Los Angeles County Fair owned by a fellow cop. Lloyd was so intrigued by the food business that he borrowed some money and opened his own food stand the following year.
To work there he recruited people he knew that could be fast and honest. He asked my mom to work weekends. She was between husbands and brought me along. I cleaned tables and Lloyd gave me a quarter a day. I worked for him on and off all the way through high school and during college breaks. I learned a great deal about customer service and marketing your product. He always gave me more responsibility when he knew I was ready.
Years later, I married his daughter and Lloyd encouraged and mentored us in our first food concession business. That turned into his helping us investigate a fast food franchise opportunity, which led us to become a multi-store operator in the High Desert.
Lloyd Lindsey taught me to work hard, to live your dream and to not to be afraid of taking a chance on yourself. That is being a father.
Right now, you are hearing a lot about "systemic racism" in America. It would be nice to have an honest conversation about the state of fatherhood in the African American community. About 70% of African American children are born out of wedlock, while married couples of color are having fewer children than ever.
Unfortunately, it seems to me that well-intentioned liberals have designed a welfare system that punishes women who choose to get married to the father to their child. The rise in illegitimate births affects all races in America, but it is particularly apparent in the African American community.
Children from two-parent families are more likely to finish high school and get some college, less likely to commit a crime or go to prison and more likely to become productive hard-working contributing members of the community in which they choose to live. Why is it so hard to redirect some of the billions we have spent over the last 60 years on social programs for the poor to family building, which is proven to break the poverty cycle?
Is it a coincidence that prior to 1965, when the "War on Poverty" swung into full gear, the social stigma against unwed mothers resulted in most pregnant couples getting married? In the 1960s and 1970s, the culture changed. Moral values changed and unwed pregnancies began to skyrocket. Benefits for dependent children were created.
There is no question that money is a major consideration to the rise of illegitimate births. It is less expensive to cohabitate than marry. The marriage commitment also binds people legally to be responsible for minor children. Commitment to anything but self has become less popular in our culture as the decades have passed. Abortion is a normal option now for unwanted pregnancy, which makes irresponsible sexual activity by men and women an accepted norm.
Why does marriage make a difference? Studies indicate that there is a 39% chance of the family breaking apart if the parents are not married. That number plummets to just 13% for married couples. Figures can be manipulated, but the clear relationship between fatherless homes, poverty, crime and poor life skills is all too evident in our major cities. The poorest city in America, Washington D.C., also has the highest rate of out-of-wedlock births. Coincidence? This cycle must be broken to achieve real racial equality.
On this day, when we celebrate fatherhood, we must ask ourselves if we have the courage to stand up and recognize that part of the reason for the disparity in the progress of minority children is the absence of two parents.
When do we return to the social and moral pressure in every community to get fathers to simply show up and be a father? How do we help that happen?
This does not mean that a white picket fence and minivan are the goals for every relationship. It means we should help young girls and women demand the self-respect of a commitment from any man with whom they partner marriage or no marriage.
Just find ways to encourage every father of every race to stand up and show up. Be a father for the future of your children, if not for yourself. That would be a great Fathers Day gift for America.
Contact Pat Orr at AVReviewOpinion@gmail.com.
Read more:
Around Town: Fathers matter - VVdailypress.com
Recommendation and review posted by Bethany Smith
A clinical trial of hydroxychloroquine has been halted after the drug was deemed ‘very unlikely to be benefici – Business Insider India
A clinical trial of hydroxychloroquine for the treatment of hospitalized adults with COVID-19 has been halted after the drug was found to be ineffective, the National Institutes of Health (NIH) announced on Friday.
According to the NIH's press release, the drug poses "no harm" to those who have taken it, but has still been deemed "very unlikely to be beneficial" to those being treated for coronavirus.
The study aimed to enroll "more than 500 adults who are currently hospitalized with COVID-19," and had enrolled more than 470 patients before it was halted, according to the NIH.
Advertisement
Though hydroxychloroquine is typically used to treat malaria and rheumatoid conditions like arthritis, according to the NIH, it had been tested to treat COVID-19 because "the drug had demonstrated antiviral activity, an ability to modify the activity of the immune system."
In recent months, hydroxychloroquine has been provided to a wide range of people across the US including 1,300 veterans infected with COVID-19.
"I take it," he said at the time. "I would've told you that three, four days ago, but we never had a chance because you never asked me the question."
More recently at the start of June, White House physician Sean Conley confirmed in a memo that Trump had been prescribed hydroxychloroquine, zinc, and vitamin D, for a two-week period. The note also stated that Trump "remains healthy" with "no findings of significance or changes to report" from his annual physical, as Business Insider's Grace Panetta previously reported.
See the rest here:
A clinical trial of hydroxychloroquine has been halted after the drug was deemed 'very unlikely to be benefici - Business Insider India
Recommendation and review posted by Bethany Smith
Low-cost blood profile screenings offered throughout the region – The Tribune – Ironton Tribune
ASHLAND, Ky. Many healthcare providers recommend patients undergo routine blood screening regularly. Kings Daughters is offering access to these tests with their Low-Cost Blood Profile program.
The blood screening is available for $25. No physician order or appointment is needed. However, fasting is required. Results will be mailed to participants homes and available in MyChart in one to two days. Cash, checks and credit cards are accepted. Insurance cannot be billed.
The LCBP includes the most commonly ordered lab tests, including:
Complete Blood Count: Screens for and monitors conditions that affect the blood cells, including anemia, infection, inflammation, blood disorders and some types of cancer.
Comprehensive Metabolic Panel: Provides information about the current status of the metabolism, including kidneys and liver; electrolyte and acid/base balance; blood glucose levels; and blood proteins.
Lipid Panel: Includes measures of total cholesterol, LDL cholesterol (bad); HDL cholesterol (good); and triglycerides.
Thyroid Stimulating Hormone: Screens for and aids in the diagnosis of thyroid disorders, including both low and high function.KDMC also offers optional A1C testing for $5. The A1C test provides information about the average levels of blood glucose over the past three months. The A1C is an important tool in the management of diabetes.All screenings take place from 8-10 a.m. The locations and dates for the screenings include:
Kings Daughters Center for Advanced Imaging, 2225 Central Ave., Ashland, Ky.; Fridays through Nov. 20.
Kings Daughters Ohio, 2001 Scioto Trail, Portsmouth, Ohio; July 17, Sept. 18, Nov. 20.
Kings Daughters Medical Specialties Kinneys Lane, 1729 Kinneys Lane, Portsmouth, Ohio; Aug. 17, Oct. 19.
Kings Daughters Family Care Center Grayson, 100 Bellefonte Rd., Grayson, Ky.; July 10, Sept. 11, Nov. 13.
Kings Daughters Family Care Center Ironton, 912 Park Ave., Ironton, Ohio; July 23, Aug. 27, Sept. 24, Oct. 22.
Kings Daughters Medical Specialties Prestonsburg, 1279 Old Abbott Mtn. Road, Prestonsburg, Ky.; July 22, Sept. 23, Nov. 25
Kings Daughters Medical Specialties Jackson, 14395 State Route 93, Jackson Ohio; July 17, Sept. 18, Nov. 20.
Kings Daughters Family Care Center Wheelersburg, 8750 Ohio River Road, Wheelersburg, Ohio; July 10, Sept. 11, Nov. 13.For the most up-to-date testing schedule, stay tuned to our Facebook page or visit the events calendar at KingsDaughtersHealth.com.
Read the original here:
Low-cost blood profile screenings offered throughout the region - The Tribune - Ironton Tribune
Recommendation and review posted by Bethany Smith
After the coronavirus, will we ever hug again? – Leesville Daily Leader
America was a nation of huggers.
We cuddled our grandchildren, embraced to provide comfort and hugged in greeting.
But COVID-19 has changed that.
Now hugging can be hazardous, carrying with it the risk of transmitting a virus that travels through close contact.
So will our culture abandon hugging?
"We're going to see a lot less hugging in the future, said Gail Saltz, an associate professor of psychiatry at NewYork-Presbyterian Weill Cornell Medical College. Shaking hands and touching the cheeks of complete strangers probably hasn't made sense for a long time, since we know how contagion works."
Embracing in the time of the pandemic is about risk management.
For many, especially those 65 and older and those with underlying medical conditions who are at high risk for COVID-19, hugging should mostly be off the table, at least until a vaccine is found, said William Li, a physician studying COVID-19 and president and founder of the nonprofit Angiogenesis Foundation.
Younger people also may be reluctant to hug parents or grandparents out of fear they might transmit the coronavirus.
The decision not to hug can actually be a demonstration of caring, Saltz said.
"There's concern about putting the older person at risk, she said.
The person who loves them would feel horrendous if they were the source of the virus."
But people miss hugging so much, they're getting creative.
One New Jersey grandmother donned a head-to-toe unicorn costume and visited her grandchildren for hugs.
Maureen Sweeney, 58, of Cinnaminson said it was overwhelming the first time she embraced her grandchildren after months without doing so.
She disinfects the unicorn between uses and even bought a shark costume for her husband.
After weeks of quarantining, Daria Lucarelli, 57, of Ventura, California, had had enough of waving to her four grandchildren from afar.
She bought clear trash bags, then cut and taped them to create two full-body plastic suits, throwing in scuba snorkels for breathing.
She and her 73-year-old husband showed up on their daughter's doorstep for hugs.
"It was electrifying, Lucarelli said. You don't realize how much you miss the hugs until you actually feel them."
The importance of touch
Hugging has both mental and physical benefits, said Asim A. Shah, the executive vice chair of the department of psychiatry at Baylor College of Medicine.
Touch is particularly important for older people, who often report feelings of loneliness, Shah said.
Human contact stimulates the brain to release the beneficial hormone oxytocin, decreasing anxiety and stress, which can boost the immune system.
One study found that hugging and emotional support make people less susceptible to illness, and with milder symptoms if they do get sick.
In a recent survey of COVID-19 lockdown activities by the Touch Research Institute at the University of Miami Miller School of Medicine, older respondents generally seemed more content at home than their younger counterparts, but many in the older group noted that what they missed most was hugging their grandchildren, said Tiffany Field, director of the institute.
Despite that, Field said she doesn't believe widespread hugging will be returning any time soon. In the future it may be reserved only for the closest circle of family and friends.
Replacements for hugging
"I don't think hugging in public is going to come back, she said.
With social distancing in place, it's important to find behaviors that can substitute, in part, for hugging, Shah said.
Interaction through video chatting platforms can simulate about 80 percent of the benefits of touching, while talking on the telephone comes in at about 50 percent, Shah said.
Enhanced communication can also go a long way to ease the lack of human touch, whether that's by text, socially distant face-to-face conversation or written letters, Saltz said. You can say, I love you so much, I wish I could hug you,' she said. Words can touch us, too."
Weighing the risks
For 60-year-old Linda Hidde, of Appleton, Wisconsin, the decision to hug her two young grandchildren came after quarantining for weeks.
The normally cheerful Hidde said she became depressed and cried daily.
"It was taking a toll on me, she said. I finally decided this had to stop."
She began visiting and hugging her grandchildren again.
But Hidde said she's taking precautions by mask-wearing and handwashing and won't interact with her grandchildren if she feels even the mildest symptoms, like a sore throat.
People should be cautious and assess the hazards involved with hugging, and use strategies to make contact safer if they choose to hug, said Theodore Bailey, chief of the division of infectious diseases at the Greater Baltimore Medical Center.
Wearing a mask and clean clothes and washing hands can help, he said.
"Most of the things we do in life have some risk associated with them, he said.
Getting rid of hugging altogether wouldn't be justifiable on medical grounds, Bailey said, noting that the pandemic is an unusual situation that won't last forever.
Bailey and his wife both work with COVID-19 patients, taking proper safety precautions, and after they shower and change clothes, they do hug their young children.
However, Bailey has not visited his 82-year-old mother who lives in another state. Instead he bought her a tablet for Zoom visits.
New rules for hugging
Hugs should be fully consensual.
Don't approach someone for a hug without discussing it first, Bailey said. This is an exceptional situation and people's comfort with risk is not the same from one person to the next, he said.
Generally, you can hug the people you're quarantined with.
The people you live with are safe to hug, unless they're working outside the home in jobs that might expose them to the virus or to a lot of people, Li said.
Convey affection in different ways.
Send emojis by text, throw kisses through video chat, read a book to grandchildren over FaceTime, express yourself through talking or writing letters, said Raquel Bild-Libbin, a Miami psychologist.
We don't want people to feel they aren't connected and loved, she said. It's just communicated in a different form."
Here is the original post:
After the coronavirus, will we ever hug again? - Leesville Daily Leader
Recommendation and review posted by Bethany Smith
Type 1 diabetics may be at high risk for severe illness related to coronavirus: Study – ABC News
People with Type 1 diabetes may be at a high risk of developing severe symptoms and illness from COVID-19, according to a new study published in Diabetes Care.
Diabetes is generally known to weaken the immune system, making it harder to protect against viral infections like COVID-19. Viruses, like the novel coronavirus, may also aggravate preexisting diabetic systems leading to added challenges managing blood sugar levels and worse outcomes.
Researchers found that about half of the people in the study with Type 1 diabetes and suspected or confirmed COVID-19 infections had abnormally high blood sugar -- highlighting how COVID-19 can complicate blood sugar control in Type 1 diabetic patients.
Having consistently high blood sugar can be a sign of diabetic ketoacidosis, a potentially fatal diabetic complication that is characterized by high blood sugar and low insulin levels. It is commonly triggered by infections.
In the study, almost half of all confirmed COVID-19 cases also developed diabetic ketoacidosis,
"This points to the need for people with diabetes to check their blood glucose often, and to keep blood glucose in good control." said Dr. K.M Venkat Narayan, professor of global health and epidemiology at Emory University, who was not involved in the study.
He added, "People with diabetes, in general, are at increased risk of adverse COVID complications, and at more than twice the risk of death from COVID than people without diabetes."
There are two main types of diabetes: Type 1 and Type 2. Type 1 diabetes is an autoimmune condition, which means that the immune system attacks the body's own cells and impairs its ability to produce insulin, a hormone that helps to control blood sugar levels. Blood sugar regulation is a complicated process, affected by multiple factors such as food, sleep, stress and illness. Type 2 diabetes, the much more common form of the disease, usually presents itself in adults and can often be controlled by healthy eating and exercise.
A patient holds insulin medicine, Jan. 17, 2020 in Minnetonka, Minn.
This study only included patients with Type 1 diabetes and a suspected or confirmed case of COVID-19.
"So far, most of the studies published have lumped together all types of diabetes. We know these conditions can be very different and we need to study them separately," said Dr. Fernando Ovalle, director of the division of endocrinology, diabetes and metabolism at the Birmingham School of Medicine, University of Alabama, who was not involved in the study.
Dr. Mary Pat Gallagher, director of pediatric diabetes at NYU Langone Health and co-author of the study said that from the data they have the risks of complications, such as high blood sugar and diabetic ketoacidosis with COVID-19, are probably similar to those seen in other viral illnesses.
However, "COVID is a more serious infection than influenza," Narayan said.
More research is needed, according to Ovalle. The study was fairly small; most people studied were in their early 20s and did not examine how the severity of COVID-19 symptoms compared to people without Type 1 diabetes.
"Much more research is needed before we can know for sure what the true risks are, particularly for Type 1 diabetes," he said.
Dr. Osagie Ebekozien, author of the paper and vice president at T1D Exchange, added, "As we collect additional data, we will be able to provide more insights on factors that contribute to increased risks of hospitalization and adverse outcomes as a result of COVID-19 for people with Type 1 diabetes."
Regardless, the Centers for Disease Control and Prevention said that diabetes, "including type 1, type 2, or gestational, may put people at higher risk of severe illness from COVID-19," and patients should take extra precautions. The agency recommends taking diabetes pills or insulin as usual, testing and keeping track of blood sugar every four hours, and having at least a two-week supply of diabetes pills or insulin.
"High glucose levels may be one factor contributing to excess risk from COVID, and therefore, attention to glucose control is key," said Narayan.
An external insulin pump is carried by a patient with Type 1 diabetes.
Experts advise that diabetics should talk to their physicians if their medications need adjustment. "It is usually possible to prevent diabetic ketoacidosis if the higher insulin requirements that are often seen with viral illnesses are addressed early in the process," said Gallagher.
A healthy lifestyle with regular exercise, balanced diet, regular sleep and stress management all help with diabetes control and "may also help boost defenses against COVID," said Narayan.
Amid the pandemic, disruptions to work, care and daily routines make it harder to maintain good blood sugar control. Experts advise vigilance and care: Take safety measures to avoid COVID-19, check blood sugar levels more frequently if feeling sick and do not hesitate to seek a physician's assistance. Serious complications are preventable with early intervention and responsible diabetes management.
ABC News' Dr. Jessica Johnson contributed to this report.
Hassal Lee, a neuroscience Ph.D., and student doctor at the University of Cambridge is a contributor to the ABC News Medical Unit.
See the rest here:
Type 1 diabetics may be at high risk for severe illness related to coronavirus: Study - ABC News
Recommendation and review posted by Bethany Smith
Ultragenyx and Kyowa Kirin Announce US FDA Approval of Crysvita (burosumab) for the Treatment of Tumor-Induced Osteomalacia (TIO) – BioSpace
NOVATO, Calif.andTOKYO, June 18, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc.(NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, andKyowa Kirin Co., Ltd.(Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions using the latest biotechnology, today announced that theU.S. Food and Drug Administration(FDA) has approved Crysvita(burosumab) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adults and pediatric patients 2 years of age and older. Crysvita is a human antibody that blocks excess activity of FGF23, a hormone that causes phosphate urinary excretion and suppresses active vitamin D production by the kidney.
For approximately half of all individuals with TIO, surgical removal of the tumors is not possible, leaving these patients with no other treatment options. The FDA approval of Crysvita marks the first treatment option that addresses the cause of the severe hypophosphatemia and osteomalacia resulting from these rare tumors, said Camille L. Bedrosian, M.D., Chief Medical Officer of Ultragenyx. We plan to leverage our experience and existing infrastructure with Crysvita in X-linked hypophosphatemia to bring this important medicine to patients living with the rare, painful and debilitating disorder of TIO.
Since its approval, Crysvita has meant a great deal to patients and families that previously had no other treatment options. We are proud of the work that has been done to advance this discovery from our labs, through a robust clinical research program, and through the FDAs priority review process, to make this treatment available to patients with TIO, said Gary Zieziula, President, North America for Kyowa Kirin. Our commitment to meeting the needs of patients with rare and serious diseases remains steadfast and we will continue to partner with the Ultragenyx team to address these needs with urgency.
TIO is a rare disease caused by typically benign, slow-growing tumors that produce excess levels of FGF23, which is involved in phosphate reabsorption. Patients with TIO can experience symptoms including severe hypophosphatemia (low levels of phosphate in the blood), osteomalacia (softening of the bones), muscle weakness, fatigue, bone pain and fractures. There are an estimated 500 to 1,000 people inthe United States with TIO, and approximately half of all cases are believed to be inoperable. In patients for whom the tumor or lesion is inoperable, the current treatment consists of oral phosphate and/or active vitamin D replacement. Efficacy of this management is often limited, and its benefits must be balanced with monitoring for potential risks.
This is the second FDA-approved indication for Crysvita, which was first approved in April 2018 for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients one year of age and older. The XLH indication was expanded in September 2019 to include infants as young as six months of age.
The FDA approval of Crysvita for TIO was based on data from two single-arm Phase 2 studies, a 144-week study in 14 adult patients conducted by Ultragenyx in theUnited Statesand an 88-week study in 13 adult patients conducted byKyowa KirininJapanandSouth Korea. In both studies, Crysvita was associated with increases in serum phosphorus and serum 1,25-dihydroxyvitamin D levels. Increased phosphate levels led to improvements in osteomalacia. Additionally, whole body bone scans demonstrated reduced tracer uptake with long-term treatment suggesting healing of bone lesions. Most common adverse reactions (>10%) in TIO patients are: tooth abscess, muscle spasms, dizziness, constipation, injection site reaction, rash, and headache.
The FDA granted Priority Review designation for the supplemental BLA for TIO, which is reserved for drugs that treat a serious condition and, if approved, would provide a significant improvement in safety or effectiveness.
To support access, Ultragenyx has a program called UltraCare, which helps patients and caregivers understand insurance coverage and assists them in finding financial support for Ultragenyx medicines including Crysvita, and for the administration of them. Dedicated in-house UltraCare Guides are available Monday through Friday from9 a.m. to 8 p.m. Eastern Timeat 888-756-8657.
About CrysvitaCrysvita (burosumab-twza) is a recombinant fully human monoclonal IgG1 antibody, discovered byKyowa Kirin, against the phosphaturic hormone FGF23. FGF23 is a hormone that reduces serum levels of phosphorus and active vitamin D by regulating phosphate excretion and active vitamin D production by the kidney. Phosphate wasting in TIO and other hypophosphatemic conditions, including XLH, is caused by excessive levels and activity of FGF23. Crysvita is designed to bind to and thereby inhibit the biological activity of FGF23. By blocking excess FGF23 in patients with TIO and XLH, Crysvita is intended to increase phosphate reabsorption from the kidney and increase the production of active vitamin D, which enhances intestinal absorption of phosphate and calcium.
Crysvita is approved by theU.S.FDA for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients six months of age and older and FGF23-related hypophosphatemia in tumor-induced osteomalacia (TIO) associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in adults and pediatric patients 2 years of age and older, and byHealth Canadaand BrazilsNational Health Surveillance Agency(ANVISA) for the treatment of XLH in adult and pediatric patients one year of age and older. InJapan, it is approved by theMinistry of Health, Labor and Welfare(MHLW) for the treatment of FGF23-related hypophosphatemic rickets and osteomalacia. InEurope, Crysvita has received European conditional marketing authorization for the treatment of XLH with radiographic evidence of bone disease in children 1 year of age and older and adolescents with growing skeletons, and an application for the expanded use in adults with XLH is currently under review by theEuropean Medicines Agency.
Kyowa Kirinand Ultragenyx have been collaborating in the development and commercialization of Crysvita globally based on the collaboration and license agreement between the parties.
U.S. INDICATIONCrysvita (burosumab-twza) is a fibroblast growth factor 23 (FGF23)-blocking antibody indicated for the treatment of:
IMPORTANT SAFETY INFORMATIONCONTRAINDICATIONS
WARNINGS AND PRECAUTIONSHypersensitivity
Hyperphosphatemia and Risk ofNephrocalcinosis
Injection Site Reactions
ADVERSE REACTIONSPediatric XLH Patients
Adult XLH Patients
Adult TIO Patients
USE IN SPECIFIC POPULATIONS
PATIENT COUNSELING INFORMATION
Side effects may be reported to the FDA at (800) FDA-1088 orwww.fda.gov/medwatch.Side effects may also be reported to Kyowa Kirin, Inc. at 1-888-756-8657.
Please see fullPrescribing Information for a complete discussion of the risks associated with CRYSVITA.
About UltragenyxUltragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyxs strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the companys website at http://www.ultragenyx.com.
AboutKyowa KirinKyowa Kirincommits to innovative drug discovery driven by state-of-the-art technologies. The company focuses on creating new values in the four therapeutic areas: nephrology, oncology, immunology/allergy and neurology. Under the Kyowa Kirin brand, the employees from 40 group companies acrossNorth America, EMEA andAsia/Oceaniaunite to champion the interests of patients and their caregivers in discovering solutions to address unmet medical needs. You can learn more about the business ofKyowa Kirinatwww.kyowakirin.com.
Forward-Looking Statements Except for the historical information contained herein, the matters set forth in this press release, including statements related to Ultragenyx's expectations and projections regarding its future operating results and financial performance, anticipated cost or expense reductions,the timing, progress and plans for its clinical programs and clinical studies, future regulatory interactions, and the components and timing of regulatory submissions are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause our clinical development programs, collaboration with third parties, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, Ultragenyxs reliance on its third party partner, Kyowa Kirin Co., Ltd., for the supply of Crysvita, the effects from the COVID-19 pandemic on the companys business and operating results, smaller than anticipated market opportunities for the companys products and product candidates, the companys evolving commercial infrastructure, uncertainties related to insurance coverage and reimbursement approval for the companys products, manufacturing risks, the uncertainties inherent in the clinical drug development process, including the potential for substantial delays and the risk that earlier study results may not be predictive of future study results, the lack of predictability in the regulatory approval process, the timing of regulatory filings and approvals (including whether such approvals can be obtained), and other matters that could affect sufficiency of existing cash, cash equivalents and short-term investments to fund operations, the companys future operating results and financial performance and the availability or commercial potential of Ultragenyxs products and drug candidates. Ultragenyx undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Ultragenyx in general, see Ultragenyx's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 7, 2020, and its subsequent periodic reports filed with the Securities and Exchange Commission.
Contacts:
UltragenyxInvestors & MediaDanielle Keatley+1-415-475-6876dkeatley@ultragenyx.com
Kyowa Kirin Co. Ltd.MediaHiroki Nakamura (Global)+81-3-5205-7205Email:media@kyowakirin.com
Lauren Walrath (US)+1-646-526-4454Email: publicaffairs.na@kyowakirin.com
Recommendation and review posted by Bethany Smith
The best and worst canned foods, according to nutritionists – CNET
Maximilian Stock Ltd. / Getty Images
With the coronaviruspandemicforcing us all to cook more often frompantry staplesand non-perishable food stashes, canned food has probably never been more popular. But what's the best canned food to stock from a nutritional point of view?
Canned foodsare convenient, affordable and easy tostock for long periodsof time. They can be a simple solution to many shopping and cooking problems. Their health implications, however, are less clear. When it comes to the nutritional value (or lack thereof) of these products, there's a wide range of opinions.
"People should treat canned foods as they would any kind of food," nutritional therapy practitioner andLife Health & Wellness CenterCEO Asher Adelman says. "When shopping for canned foods, the best choices are real whole foods that aren't processed and that don't contain refined grains, sugar or inflammatory vegetableoilslike corn, canola and soybean oils."
Time to get more specific! Here are the details about the best and worst canned foods you can buy (for yourself orto donate), according to nutritionists and other nutrition experts.
Read more:How to safely grocery shop during a pandemic
According to Gabrielle McGrath, MS, RN, LDN ofLexi's Clean Living, canned pumpkin is great to have on hand for its slew of health benefits. The nutrients and antioxidants in plain and cannedpumpkin puree(without other additives) can boost your immune system, protect your eyesight, and lower your risk of chronic disease. Look for brands that list simply "organic pumpkin" on the ingredients list.
Certified nutrition therapy practitionerHaley Haltemanis cautious about the high sodium content of most canned foods, but she notes that canned chicken,salmon,tunaandsardinescan be great for a quick, high-protein meal as long as the quality is right. Choose brands that are "organic, from pasture-raised or wild-caught sources, packaged in water, with no salt added."
There are plenty of healthy options available in the canned vegetable section at your local supermarket, but registered dietitianJen Hernandezencourages you not to gettoocarried away, focusing instead on the canned veggies you think you'll actually eat. Hernandez is a big fan of cannedcorn,green beansandpeas, all of which are best for you when marked low sodium and no added salt.
McGrath regularly stocks diced tomatoes in her own kitchen for use inchilis,soupsandtomato sauces. Citric acid and calcium chloride are two ingredients frequently found in canned tomatoes and are nothing to be concerned about, according to McGrath.
Read more:A comprehensive guide to canned tomatoes
Registered dietitianBri Bellrecommends keeping cannedbeansandlentilsin your pantry. These legumes are healthy sources of protein, fiber and carbohydrates, and can be easily added to everything from soups andchilistosaladsandgrain bowls. Steer away from added salt whenever possible.
Read more:The best ways to use all the beans in your pantry
Even for the "good" canned products listed above, there can be some variation in terms of ingredients and preparation.Stick to versions ofallcanned foods with low sodium and no added sugar.
"It's important to keep in mind there are unhealthy versions of anything canned," McGrath says. "You need to look at thenutrition facts panelso you can fully understand what you are eating."
And then there are the canned foods that should be avoided almost all the time
While many nutrition pros swear by the health benefits of canned beans, McGrath is cautious about purchasingbakedbeans in a can. Canned baked beans, she says, are often loaded with saturated fat, sugar and unnecessary additives. If you lovebaked beans, go the homemade route, instead.
Sorry to burst your bubble on your favorite feel-good canned soups, but many of these products arenotapproved by nutritionists. "A no no for me is canned soups," Hernandez says. "Not only are they often more than a day's worth of sodium, they just don't taste as good as homemade!" Making homemadesoupis a commitment, but don't be intimidated -- there are plenty of manageable DIY recipes out there for everything fromEasy Lentil SouptoClassic Tomato Soup.
Read more:How to make easy crock-pot chicken stock in the slow cooker
Therearesome canned fruit options that can be a healthy snack or add-on to yogurt or oatmeal, but nutritionistLisa Richardsnotes that many brands package their fruit in syrup. This does, of course, help retain the fruit's sweet taste, but it's also high in added sugar, which can increase inflammation and contribute to poor gut health.
Canned pastas (like the o-shaped ones you loved when you were a kid) and other ready-made meals can be convenient to have around in a pinch, but they're not recommended from a health perspective.Kiss My Ketoregistered dietitian Sofia Norton names these products among the worst canned options in the game, primarily because of their high levels of preservatives, additives, salt, and sugar.
Read more:Three pantry pasta recipes for when the fridge is bare
More generally, when reviewing your canned food options, Halteman recommends paying special attention to the way the can itself is made. Some brands use toxic chemicals likeBPAto make their cans.BPAis an endocrine disruptor andcan cause problemswith hormone levels and increase the risk of heart complications, cancer, and other diseases. "This is the number-one thing to look for!" Halteman says.
It should be noted that as consumer awareness about and backlash to BPA has increased,many manufacturers have stopped using it(even if the labels don't say so), but if you want to be extra-safe, you may still want to stay away from canned foods that aren't specifically labeled BPA-free.
Read more abouthow to stock a pantrybeyond canned goods.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.
Follow this link:
The best and worst canned foods, according to nutritionists - CNET
Recommendation and review posted by Bethany Smith
Joy Bauer of the ‘Today Show’ Shares 3 Easy Ways to Boost Your Immune System – Showbiz Cheat Sheet
NBCs Today Show health expert Joy Bauer knows that a strong immune system is vital to help ward off disease.
Reducing stress, exercising, eating antioxidant-rich foods, and getting a good nights sleep can help individuals stay healthy, especially during a pandemic. Although eating a bowl of chips while binging on Netflix may have been the norm at the beginning of the crisis, Bauer says now is the time to get off the couch, nourish your body with healthy foods, and get a good night of sleep.
She told Showbiz Cheat Sheet that boosting your immune system doesnt have to be complicated, require an expensive gym membership, or involve a complex nutrition plan.
Its really a combination of looking and feeling our best, she says. But at the same time every single physician you talk to now, they make strengthening the immune system their top priority.
Bauer acknowledged that a number of Americans are re-emerging into society after being in a COVID-19 cocoon. Some people may have added a few pounds to their frame due to the stress of being locked down too.
But she views this as a unique opportunity for Americans to get serious about their health. Because its about survival, she remarks. One transformative aspect of the lockdown is that many people have become better home chefs. So rather than hitting the same pasta recipe, Bauer suggests weaving immune-boosting foods into meals.
RELATED: Today Shows Joy Bauer Says These 4 Foods Can Keep You Looking Young
Specifically [meals] loaded with produce and antioxidants, she suggests. Now is the time to find recipes that you can create around your repertoire and learn how to make things that are healthy and immune-boosting.
Plan out your week with at least three or four meals for each meal category, to keep the variety fresh. Thinking ahead means youll be better prepared at the grocery store and more likely to save money. Going back to the office? Double up on the recipes, portion out sizes, and store extras in the freezer. When its time to head to work, grab a packaged meal, and go. Dont forget to date your stored items.
Bauer recommends integrating Vitamin C immune-rich produce, such as citrus and mangos, into daily meals. Also, consider zinc to boost your immune system. Zinc-rich foods include cashews and pumpkin seeds.
RELATED: Foods That You Should Never Touch If Youre Over 50
Vitamin D is also important. It plays a major role in the immune system, she says. Milk and milk alternatives are good sources. But the important resource is salmon. The omega-3 fats with salmon are so great for every part from head to toe of your body, she says. Bauer also shared three immune-boosting recipes. They include loaded bell pepper nachos, plus her longevity smoothie and mango-ginger cashew smoothie.
Not feeling comfortable going back to the gym just yet? Bauer says taking a walk every day will give you the immune-boosting exercise your body craves. The easiest thing anybody can do to boost their immune system, mood and regulate weight from the exercise standpoint is just put on your sneakers and walk for at least 30 minutes a day, she remarks.
RELATED: 5 Healthy Habits You Should Remember Every Day
Its so simple and the health payoff is tremendous, Bauer adds. I always tell people to do it first thing in the morning because I think it sets you up to have a productive day. We know from research it boosts your mood. Harvard Health cited additional benefits, which include a possible cancer risk reduction, reduced sugar cravings, and less joint pain.
Bauer suggests using the time to catch up with friends on the phone or to listen to a book on tape. Make a deal that you are only going to listen to the audio when you are exercising, she suggests. Also, find a podcast to dive into for fun.
Bauer says the third key to a strong immune system is getting a good night of sleep. Sleep has gotten so much attention within this last year, even prior to the COVID stuff, she says. Being sleep deprived is directly related to increased levels of stress, being overweight, and having Type 2 diabetes. Also having memory issues.
RELATED: Today Show: Former Co-Host Kathie Lee Gifford Said She Would Get Creamed For Talking About This On the Air
People should try to aim for seven to eight hours a night, she recommends. But with people experiencing anxiety and stress, how can you still grab those vital hours of shut-eye? One of the things people can do is drink a calming cup of chamomile tea, Bauer says. Avoid drinking alcohol and also keep technology, such as phones and tablets, out of the bedroom.
And melatonin for sure, she says. Melatonin is a hormone and it helps to regulate our sleep-wake cycle. Bauer recently partnered with Life Extensions Fast- Acting Melatonin. Its a citrus vanilla [flavor], she describes. And it helps you get a restful sleep pattern.
See the original post:
Joy Bauer of the 'Today Show' Shares 3 Easy Ways to Boost Your Immune System - Showbiz Cheat Sheet
Recommendation and review posted by Bethany Smith
Upgraded Regenerative Stem Cell Exosome Joint Injection Medical Therapy Launched – Newswire
Enhanced, chronic joint pain treatment has been launched by The Aspen Institute for Regenerative Medicine. Dr. Gershon helps patients nationwide to overcome pain and injury.
(Newswire.net -- June 20, 2020) -- Enhanced, chronic joint pain treatment has been launched by The Aspen Institute for Regenerative Medicine. Dr. Gershon helps patients nationwide to overcome pain and injury while avoiding surgery.
The Aspen Institute for Anti-Aging and Regenerative Medicine has launched an updated service for nationwide patients. Anyone across the US needing the very best in stem cell therapy and exosome treatments can get in touch wit Dr Julian Gershon Jr. He is triple board certified in Family Medicine, Sports Medicine, and Anti-Aging and Regenerative Medicine, with decades of experience in stem cell therapy. He specializes in chronic joint pain primarily in the shoulders, knees, hips, and ankles.
More information can be found at: https://www.aspen-regenerativemedicine.com
Aspen Institute for Anti-Aging and Regenerative Medicine has developed a reputation for excellent service and exceeding client expectations. This has led to the Aspen Institute becoming a nationwide leader in the latest cutting-edge non-invasive treatments for chronic joint pain and healthier aging. Their focus has been on shifting from disease management medicine to optimal health and quality of life based medicine.
Now, through their newly updated services, the Aspen Institute is providing nationwide clients with stem cell therapy, exosome therapy, bio-identical hormone therapy, protein rich plasma PRP injections, and other healthcare solutions that can both improve and maintain beauty and health.
Treatments are centered around regenerative medicine that is evidence based, proactive, and synergistic. In this way, the Aspen Institute for Anti-Aging and Regenerative Medicine help patients to regain control over their health and enjoy happier, healthier, and more active lives.
They serve professional athletes and discerning clientele that demand the very best in alternatives to surgery. The team uses cutting-edge technology for umbilical cord and blood-derived stem cell procedures. Clients come from Denver, across the USA, and further to receive the highest quality treatments available in the world.
Athletes also benefit from an on-site board-certified sports medicine physician. For those seeking stem cell therapy, exosome therapy, and the best regenerative medicine, The Aspen Institute offers the highest quality results that can be achieved at this time.
Alternatives to surgery can be found with non-invasive treatments, anti-aging solutions, and regenerative platelet-rich plasma therapy.
Nationwide patients can visit Dr Julian Robert Gershon Jr in Lakewood or Aspen to discuss their health requirements. The treatments on offer are ideally suited to combating Achilles tendinitis and tears, back pain, arthritis, hip pain, knee pain, neck pain, tennis elbow, and more.
Patients benefit from non-invasive treatments that allow them to get back to fitness faster. These are pain free, and offer increased tissue repair. They also help with the reduction of inflammation and promote new blood vessel growth.
Full details can be found on the URL above.
Follow this link:
Upgraded Regenerative Stem Cell Exosome Joint Injection Medical Therapy Launched - Newswire
Recommendation and review posted by Bethany Smith
How to Safely Store Hand Sanitizer in Your Car This Summer – POPSUGAR
Summer is here, but one thing hasn't changed: we still need to do our part to prevent the spread of the novel coronavirus. Toting hand sanitizer around has become the norm and, for many people, that includes keeping an extra bottle in the car. But is that habit safe as the temperatures rise? Could the heat render the hand sanitizer ineffective?
While you may have seen rumors circulating on social media that hand sanitizer can "explode" in a hot car, you won't end up with a fire on your hands if you keep a bottle stashed away. "For hand sanitizer to explode, the temperature would have to reach almost 700 degrees Fahrenheit to start a fire," Kathleen Dass, MD, at the Michigan Allergy, Asthma and Immunology Center, told POPSUGAR. "Even at the hottest temperature over the summer, studies show the maximum temperature most cars will reach is 160 degrees."
However, you should avoid leaving hand sanitizer in direct sunlight in a hot car. Hand sanitizer needs to have at least 60 percent alcohol content to be effective. "Prolonged heat and sunlight exposure can make the hand sanitizer less effective because the alcohol can evaporate," Dr. Dass said. She also noted that having sanitizer in a clear bottle can raise the temperature. Jeffrey Toll, MD, an internal medicine physician in Los Angeles, told POPSUGAR that in order to avoid any potential degradation of the sanitizer's quality, you should keep it away from direct sunlight if you're in the car for a long period of time.
Although keeping hand sanitizer in a hot car won't cause a fire, Dr. Toll said it's important to remember that it is flammable because it contains alcohol so you should always be mindful of where you store it and make sure to keep it away from any open flame. Dr. Dass added that when storing it in your car, make sure it's not anywhere near the car's cigarette lighter. But purely for COVID-19 purposes, the most important thing is to keep it in the coolest space possible. "Store it in a cool, shaded, or partially shaded place in your vehicle," Dr. Toll said. "And remember that it is not a replacement for soap and water, just an alternative to use when soap and water are not available."
Continued here:
How to Safely Store Hand Sanitizer in Your Car This Summer - POPSUGAR
Recommendation and review posted by Bethany Smith
Netflix Has a Bunch of Hidden Movies and TV Shows You Don’t Know About – Yahoo Lifestyle
These are the secret codes you need to find them.
From Men's Health
Netflix Has a Bunch of Hidden Movies and TV Shows You Don't Know About
Netflix has none of what you don't want (commercials) and more of what you do (movies, shows, and specials) but if you find yourself watching the same episodes of The Office over and over again, it's time to rethink your queue. The dizzying amount of choice on your favorite streaming platform can feel overwhelming at times, but with the right tricks up your sleeve, you can find exactly what you want to watch without spending an hour clicking through those never-ending feeds.
Browse with secret codes.
Netflix organizes all of its content into special categories thousands of them in fact. You can explore each genre by typing its unique number after the web address: http://www.netflix.com/browse/genre/X, with X being the code. So the next time you're mindlessly scrolling through the homepage, jump to exactly what you want using one of these special shortcuts.
If you need something for the kids ...
Zero in on specific age groups or fam favorites (Disney!) by clicking straight onto one of these categories:
Children & Family Movies: 783
Disney: 67673
Education for Kids: 10659
Family Features: 51056
Kids TV: 27346
Movies based on childrens books: 10056
Movies for ages 0 to 2: 6796
Movies for ages 3 to 4: 6218
Movies for ages 5 to 7: 5455
Movies for ages 8 to 10: 561
Movies for ages 11 to 12: 6962
If you need to laugh ...
For when the new Ellen Degeneres special is not enough:
Comedies: 6548
Cult Comedies: 9434
Dark Comedies: 869
Slapstick Comedies: 10256
Stand-up Comedy: 11559
If you need to cry ...
Grab the tissues and get ready to sob your way through one of these:
Tearjerkers: 6384
Emotional Movies: 4136
If you want something to watch on date night ...
Cozy up on the couch with your significant other for a crowd-pleaser:
Action & Adventure: 1365
Action Comedies: 43040
Biographical Dramas: 3179
British Movies: 10757
British TV Shows: 52117
Dramas: 5763
Dramas based on Books: 4961
Dramas based on Real Life: 3653
Mysteries: 9994
Period Pieces: 12123
Sci-Fi Adventure: 6926
If you're over Netflix originals ...
Sometimes the streaming service gets a little too ambitious promoting its own content. You could try installing the "No Netflix Originals" Chrome extension to remove them completely from your browse page or jump ahead to one of these categories ahead:
Classic Movies (31574)
Classic Comedies (31694)
Classic Dramas (29809)
Classic TV Shows (46553)
Cult Movies (7627)
Cult TV Shows (74652)
If you want something light on in the background ...
Not in the mood for complicated plot lines and whispered dialogue? These don't require a lot of brain space after a long day.
Food & Travel TV: 72436
Food & Wine: 3890
Reality TV: 9833
Home Improvement: 3293
Science & Nature Documentaries: 2595
Science & Nature TV: 52780
Travel & Adventure Documentaries: 1159
If you want to binge ...
Hint: When "one more episode" turns into 10, go to "My Profile" and then "Playback Settings." There's an option to uncheck "Play next episode automatically." But we won't judge you for spending an hour (or 10) on one of these categories:
Classic TV Shows: 46553
Crime TV Shows: 6146
TV Action & Adventure: 10673
TV Comedies: 10375
TV Dramas: 11714
TV Mysteries: 4366
TV Sci-Fi & Fantasy: 1372
If you're in the mood for romance ...
From the light and happy rom-com to steamy Romance with a capital R, these will have you feeling some type of way.
Romantic Movies: 8883
Romantic Favorites: 502675
Romantic Dramas: 1255
Steamy Romantic Movies: 35800
Classic Romantic Movies: 31273
Romantic Comedies: 5475
Romantic Christmas Films: 1394527
Romantic Movies based on Books: 3830
Romantic Movies based on Real Life: 3963
To sort movies by year ...
On your computer, go to a category page (like Romantic Comedies) and look for a box with four dots on the upper right hand side of the page. From the dropdown menu, you can change it from "Suggestions for you" to sort by year released, alphabetical, or reverse alphabetical order.
To add in expert reviews ...
If you question what Netflix considers "critically acclaimed" (us too), filter in another layer of critiques by installing the Google Chrome extension RateFlix. The free add-on will display IMDb ratings, Rotten Tomato percentages, and Metacritic scores right next to the movie description before you accidentally click on Bright.
To watch titles before they expire on Netflix ...
Check websites like What's on Netflix and Just Watch. They'll tell you what's brand-new on the service and what's about to leave, so you can stream it before it disappears.
See more here:
Netflix Has a Bunch of Hidden Movies and TV Shows You Don't Know About - Yahoo Lifestyle
Recommendation and review posted by Bethany Smith
Queer Eye star Bobby Berk addresses jokes about him doing the most work on the show – Yahoo Lifestyle
Bobby Berk, one-fifth of Netflixs Queer Eye, has been at the center of an ongoing joke about how he gets the most work done... .
and doesnt get enough screentime for it pretty much since the show started.
Now, it appears Bobby himself
has caught on to the joke.
A new season of Queer Eye dropped on Netflix on June 5, so naturally new memes, tweets and TikToks have come out of the woodwork.
According to TikTok user geneleave, Bobby
actually duetted one of her TikToks.
with a facial expression that seemed
to imply that he totally agrees that
he does the most work on the show.
Bobby has since deleted the duet,
but a Twitter user managed to
record it before it disappeared
Follow this link:
Queer Eye star Bobby Berk addresses jokes about him doing the most work on the show - Yahoo Lifestyle
Recommendation and review posted by Bethany Smith
Male Hypogonadism Therapy Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2026 – CueReport
A new business intelligence report on Global Male Hypogonadism Therapy market by Player, Region, Type, Application and Sales Channel is designed covering micro level of analysis by manufacturers and key business segments. The Global Male Hypogonadism Therapy market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing.
The research report on Male Hypogonadism Therapy market comprises of an in-depth analysis of this business vertical, while evaluating all the segments of this industry landscape. The report provides with key insights regarding the competitive ambit as well as gross earnings of key market players. Moreover, the information concerning the regional contribution and the competitive landscape of the market is cited in the report.
Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/6901
The COVID-19 pandemic has compelled various governments to impose strict lockdown which in turn has halted the operations and processes of several firms as well as manufacturing facilities, thereby affecting global economy. Additionally, numerous enterprises across the globe are witnessing scarcity of labor along with insufficient raw materials owing to the disease outbreak, which is estimated to result in modification in the growth of Male Hypogonadism Therapy market in the forthcoming years.
Request Sample Copy of this Report @ https://www.cuereport.com/request-sample/6901
Emphasizing on the competitive spectrum of Male Hypogonadism Therapy market:
Highlighting the major parts from the Male Hypogonadism Therapy market report:
Elaborating on the regional scope of Male Hypogonadism Therapy market:
Global Male Hypogonadism Therapy Market: Segment Analysis
The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the Male Hypogonadism Therapy market growth.
Global Market: Competitive Landscape
In the competitive analysis section of the report, leading as well as prominent players of the global Male Hypogonadism Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
Other aspects of Male Hypogonadism Therapy market research report:
Key Questions Answered in Global Male Hypogonadism Therapy Market Report: -
The Report Provides The Following Information:
Request Customization on This Report @ https://www.cuereport.com/request-for-customization/6901
See the rest here:
Male Hypogonadism Therapy Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2026 - CueReport
Recommendation and review posted by Bethany Smith
No fountain of youth: Just because theres a way to boost testosterone doesnt mean you should, experts warn – Lexington Dispatch
Testosterone therapy ads promise to help aging men recapture their vitality, decrease body fat and enhance libido. But hormone treatments while medically necessary for some men arent meant to be a fountain of youth, and experts warn more research is needed to determine if such therapy could boost heart disease risks.
Testosterone levels naturally decline in most men as they age. This decline is generally mild, and symptoms often are nonspecific, such as low energy, reduced muscle mass and reduced vigor. Roughly 20% of men over the age of 60 have experienced a drop in testosterone levels, though this gradual decline can begin as early as the mid-30s.
While that can be frustrating, experts say its not a clinical indication of a need for testosterone therapy, nor is there any evidence that therapy is effective for treating those symptoms. The Food and Drug Administration has limited approval of testosterone therapy to the treatment of organic hypogonadism, a dramatic drop in testosterone caused by disease or injury of the hypothalamus, pituitary gland or the testes.
If testosterone therapy is used appropriately in men with organic hypogonadism, then there is no controversy, said Dr. Shehzad Basaria, associate director of Mens Health: Aging and Metabolism at Brigham and Womens Hospital in Boston. The condition causes specific symptoms such as decreased sexual desire, breast enlargement, testicular atrophy and hot flashes.
But in middle-aged and aging men who have a slightly lower testosterone level and nonspecific symptoms due to aging or obesity, testosterone therapy is not indicated. Similarly, testosterone is not a rejuvenation drug, said Basaria, an associate professor of medicine at Harvard Medical School. The majority of patients seen in our clinics have symptoms such as fatigue, weight gain, muscle loss or feeling sad. These symptoms are common and nonspecific, and testosterone therapy is generally not indicated in such clinical scenarios.
Over the past two decades, intense direct-to-consumer marketing of hormone therapy for aging men, much of it via television ads, has more than doubled its off-label use. Its a trend experts warn is medically unwarranted and potentially harmful.
The American College of Physicians, which issued new guidelines in January, recommends against prescribing testosterone therapy to boost energy, vitality or physical function, but supports its use for men experiencing sexual dysfunction. The recommendation calls for discussing potential benefits and risks with the patient and discontinuing treatment after one year if there is no improvement.
I think one of the biggest concerns about testosterone therapy is whether it is really needed, said Dr. Robert Eckel, professor of medicine and an endocrinologist at the University of Colorado School of Medicine in Aurora, Colorado. Erectile dysfunction is a common problem as men age, but there can be other reasons for this, such as vascular disease or nerve damage, which is more common in patients with diabetes. It is not necessarily an indication for treatment with testosterone therapy. The patient must be properly evaluated.
The FDA warns against prescribing testosterone therapy for age-related hormonal decreases or anything other than a medical diagnosis of hypogonadism. Since 2015, it has required testosterone product labels to warn of a possible increased risk of heart attacks and stroke.
But research about that association so far is unclear, Basaria said
Some studies have reported higher cardiovascular risk with testosterone use but there are an equal number of studies showing that it does not increase cardiovascular risk, he said. This discrepancy exists because no study published to date has been powered to assess cardiovascular events as the primary outcome.
Eckel, president of medicine and science for the American Diabetes Association and a past president of the American Heart Association, agreed. The cardiovascular disease outcome story is not convincing one way or another. I think to make a strong statement here would be a mistake.
See more here:
No fountain of youth: Just because theres a way to boost testosterone doesnt mean you should, experts warn - Lexington Dispatch
Recommendation and review posted by Bethany Smith
Emerging Opportunity in Transdermal Testosterone Market with Eminent Key Players and Future Outlook to 2024: AbbVie, Teva, Perrigo, Endo…
The most advanced study released by AMR on the Transdermal Testosterone market comprising key market segments such as Type, Application, Sales, Growth, Comprises details of companies manufacturing field, production volume, capacities, value chain, product specifications, raw material sourcing strategies, concentration rate, organizational structure, and distribution channel.
The COVID-19 outbreak is now traveling around the world, leaving a trail of destruction in its wake. This report discusses the impact of the virus on leading companies in the Transdermal Testosterone sector.
The research is a precise offset bridging both qualitative and quantitative data of Transdermal Testosterone market.
The study provides historical data to compare for evolving Sales, Revenue, Volume, Value of 2014 to 2019 and forecasted till 2026.
It becomes necessary to analyze the competitors progress while operating into the same competing environment, for that purpose, the report provides thorough insights into market competitors marketing strategies which include alliances, acquisitions, ventures, partnerships, as well as product launches, and brand promotions.
Transdermal Testosterone Market with Impact Analysis of COVID-19: Key Major Players areAbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddys Laboratories, Upsher-Smith Laboratories, Allergan, Cipla Inc..
Sample PDF Copy Instantly in your email box at: https://www.amplemarketreports.com/sample-request/global-transdermal-testosterone-market-1755445.html
Transdermal Testosterone Research objectives
Focuses on the key global Transdermal Testosterone players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few years.
Competitive Structure and analysis of The Transdermal Testosterone Market:
Some of the players have a stellar growth track record for 2014 to 2018, some of these companies have shown tremendous growth by sales and revenue while net income more than doubled in the same period with performing as well as gross margins expanding. The growth in gross margins over the years points to strong pricing power by the company for its products, over and above the increase in the cost of goods sold.
The report further features analysis that contains details of companies manufacturing base, production volume, sizes, value chain, product specifications.
According to AMR, key market segments sales will traverse the $$ mark in the year 2020. Unlike classified segments by Type (Gel, Patch, Solution), by End-Users/Application (Primary hypogonadism, Hypogonadotropic hypogonadism, Late-onset hypogonadism).
2020 report version is the most advanced which is further divided and highlights a new emerging twist of the industry.
Transdermal Testosterone market will increase from $XX million in 2019 to strike $YY million by 2026, with a compound annual growth rate (CAGR) of xx%. The most robust growth is anticipated in Asia-Pacific, where CAGR is presumed to be ##% from 2019 to 2026. This prediction is good news for market players, as there is good potential for them to continue developing alongside the industrys projected growth.
Find out more on growth of Transdermal Testosterone market at: https://www.amplemarketreports.com/report/global-transdermal-testosterone-market-1755445.html
Market players have determined strategies to offer a whole host of new product launches within several markets around the globe. Remarkable models are variant to be launched in eight EMEA markets in Q4 2019 and 2020. Acknowledging all-around exercises some of the players profiles that would be worth reviewing are AbbVie, Teva, Perrigo, Endo Pharmaceuticals, Acerus Pharmaceuticals, Lupin, Dr. Reddys Laboratories, Upsher-Smith Laboratories, Allergan, Cipla Inc..
Although recent years might not be that inspiring as market segments have registered reasonable gains, things could have been better if manufacturers would have plan-driven move earlier. Unlike past, but with a decent estimate, investment cycle continuing to progress in the U.S., many growth opportunities ahead for the companies in 2020, it looks like a good for today but stronger returns can be expected beyond.
Get to know about Discount at: https://www.amplemarketreports.com/discount-request/global-transdermal-testosterone-market-1755445.html
Report Answers Following Questions:
Thanks for reading this article, you can also get individual chapter wise section or region wise report versions like North America, Western / Eastern Europe or Southeast Asia.
With the given market data, Research on Global Markets offers customization according to specific needs.
About Author
Ample Market Research provides comprehensive market research services and solutions across various industry verticals and helps businesses perform exceptionally well. Our end goal is to provide quality market research and consulting services to customers and add maximum value to businesses worldwide. We desire to deliver reports that have the perfect concoction of useful data. Our mission is to capture every aspect of the market and offer businesses a document that makes solid grounds for crucial decision making.
Contact Address:
William James
Media & Marketing Manager
Address: 3680 Wilshire Blvd, Ste P04 1387 Los Angeles, CA 90010
Call: +1 (530) 868 6979
Email: sales@amplemarketreports.com
https://www.amplemarketreports.com
Recommendation and review posted by Bethany Smith
My Irregular Periods Turned Out To Be A Prolactinoma Brain Tumor – Women’s Health
I was a 27-year-old working as a freelance photographer and writer in Phoenix, Arizona, when I started having irregular periods. It was the spring of 2018, and I began to have spotting outside of my normal menstrual cycle, unbearable cramping before and after my period, cystic acne, and extreme fatigue. For months, even routine activities like taking a shower left me totally exhausted.
At the time, I thought that maybe my health issues were brought on by my diet or stress, and theyd pass if I just changed up some things. For instance, I tried eliminating dairy and gluten, but nothing changed.
Four months into my strange symptoms, I started to seriously question what was going on. After a lot of Google searches, I was convinced that I had polycystic ovary syndrome (PCOS), a hormonal disorder that causes irregular periods. I wanted to see a doctor ASAP.
After my results came in, the nurse practitioner told me that my blood contained high levels of prolactin, a hormone that typically triggers your body to produce breast milk when youre pregnant (though I wasnt pregnant or producing any breast milk). Then my heart skipped a beat: She told me she suspected I had a brain tumor and we should do further testing. My mind went to the worst possible place. A brain tumor, really?
Leaving the office, I was flooded with questions and anxiety. I knew that I needed to act fast to get a diagnosis and proper treatment. A week and a half after my initial appointment, I returned to my ob/gyns office for additional blood work. Again, my prolactin levels were higher than normal.
The next step was an MRI, which revealed that I did indeed have a brain tumor.
Thankfully prolactinomas are not cancerous. And it's not totally clear why they develop in some people. But if left untreated, it could wreak havoc on my hormones, driving up prolactin levels and causing a decrease in sex hormones like estrogen, as my doctor explained. And I already knew all too well the hormone impact this tumor could have, given the out-of-whack periods and other body problems I was experiencing. Over time, the tumor could even grow large enough to impact my vision (a scary thought, to say the least).
Because this wasnt something my ob/gyns office could treat, I had to find an endocrinology specialist to figure out next steps. In late July 2018, I connected with an endocrinologist but wasnt satisfied with the level of care she offered. She didnt explain anything about what having a prolactinoma actually meant. It felt as if she just wanted to treat me hastily and move on. I didnt feel comfortable, so I kept looking for a better fit.
Courtesy
A week or so later, I was talking with a friend and told her that I was unhappy with my treatment plan so far. She recommended the Mayo Clinic, as she had a family member who had been treated there for cancer, and he was happy with his experience and care. Down to give it a try, I submitted an application to be a patient at the Mayo Clinic in mid-August 2018. By the end of the month, my case had been reviewed, and I went in for my first consultation.
Over the course of a month, I met with doctors from three medical departments (neurological surgery, neurology, and endocrinology). Each of them explained what was going on in detail, and I was able to examine the imaging scan of my brain and tumor alongside them.
Because my tumor was too small to be surgically removed, my doctors decided that the best course of treatment for me was to take a medication that helps lower your bodys prolactin levels and may stop the tumor from growing or even shrink it.
Chances are, Ill have to take this medication for the rest of my life to keep my tumor in check. I may also have to switch up meds (or stop taking meds for a while) if my husband and I try to have kids, though my doctor says we can discuss this more in-depth when the time comes. I also visit my endocrinologist every six months for blood work, and I get a routine MRI every year or two to monitor my tumor.
Courtesy
These days, my cycle isnt 100 percent back to normal, but its pretty close. Instead of constant spotting and bleeding, I just have light spotting in the days leading up to my period. My acne faded within a couple of months, too. While my medication does come with some side effects, like headaches and drowsiness, the extreme fatigue has waned as well.
When I was first diagnosed with a prolactinoma, I didnt know anyone who was going through this. As I began to seek out resources on prolactinomas, I had a hard time finding any. This inspired me to create my own.
Today, I use my Instagram and a podcast called Fit Me Daily to connect with other women who have prolactinomas and to share the resources I wish were out there when I was first diagnosed with mine. Putting these platforms together has been therapeutic for me, and I hope that other women might find them helpful as they navigate their own health journeys.
My takeaway: If something doesnt seem quite right, its probably not. Trust your gut, advocate for yourself, and seek out treatment options that youre comfortable with. Im so glad that I did.
This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io
This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.
Originally posted here:
My Irregular Periods Turned Out To Be A Prolactinoma Brain Tumor - Women's Health
Recommendation and review posted by Bethany Smith